Hematology and Medical Oncology

An Open Access, Peer Reviewed Journal
NLM ID: 101695840
Impact-Factor: 1.96*
Online ISSN: 2398-8495

Volume 06, Issue 03


Challenges of oral antithrombotic therapy in breast cancer patients treated with cyclin-dependent kinase inhibitors: A case report

Jorge Illarramendi MD Nuria Aymerich MD María Herrera MD Julia Coll MD Jose Juan Illarramendi MD

Case Report-Hematology and Medical Oncology (HMO)

July 12, 2021


STAMP inhibitor Asciminib and medium-chain fatty-acid derivative AIC-47: novel therapies for chronic myeloid leukemia

Satoshi Uchiyama Haruka Shinohara SungGi Chi Rikako Tabata Yong-Mei Guo Junichiro Yuda Takaaki Ono Yosuke Minami

Review Article-Hematology and Medical Oncology (HMO)

July 15, 2021


Abdominal inflammatory myofibroblastic tumour in a 4 month old baby- A case report

Abhishek Kumar Jha Lipika Lipi Meera Luthra Kulbir Ahlawat

Case Report-Hematology and Medical Oncology (HMO)

July 23, 2021


About Journal


Hematology and Medical Oncology is an open access journal with comprehensive peer review policy and a rapid publication process.  Hematology journal is a novel journal that will focus on clinical as well as basic science research reports in hematology and oncology including all major types of malignancies, blood disorders, and experimental therapies.

This journal provides an integrated view of modern oncology across all disciplines and welcomes all cancer type studies and has a particular focus on and not limited to: metastasis, epidemiology, cancer research, biomarkers, prevention, pathology, radiology, cancer treatment, clinical trials, multimodality treatment and molecular biology, microenvironment, immunology and immunotherapy, targeted and next-generation therapeutics, chemotherapy and radiotherapy, mechanisms of resistance, clinical trials, genomics, epigenomics and precision medicine, epidemiology.

Hematology journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors and also accept papers on clinical research with clinical trials, including investigator-initiated, NCI-sponsored and pharmaceutical industry sponsored phase I-III trials. Hematology journal includes translational studies applying basic science to clinical issues are particularly welcomed.

Hematology journal will feature original research, review papers, clinical studies, editorials, expert opinion and perspective papers, commentaries, case reports, brief reports and book reviews etc.,

Hematology journal welcomes direct submissions from authors: Attach your word file with e- mail and send it to submissions@oatext.com alternatively to editor.hmo@oatext.com

Please, follow the Instructions for Authors. In the cover letter add the name and e-mail address of 5 proposed reviewers (we can choose them or not).

Copyright is retained by the authors and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by Hematology and Medical Oncology, is properly cited

*2020 Impact Factor is the ratio of the number of citations achieved in the year 2020 based on Google Search and Google Scholar Citations to the total number of articles published in the last two years i.e. in 2018 and 2019. Impact factor measures the quality of the Journal. If ‘X’ is the total number of articles published in 2018 and 2019, and ‘Y’ is the number of times these articles were cited in indexed journals during 2020 then, impact factor = Y/X.

Ciro Rinaldi


Professor Ciro Rinaldi trained in Italy at University Federico II Naples, where he gained his MD, followed by Haematology specialist training and a PhD in Biotechnology.  During his PhD, he moved to Chicago where he worked in Giuseppina Nucifora’s Lab at University of Illinois (UIC), and he published several articles on alternative pathways in MPN and MDS.

He is Consultant Haematologist at United Lincolnshire Hospital Trust specialised in MPN, MDS, Myeloma and Lymphoma and he is also Clinical Director for Clinical Support Services and Deputy Director Clinical Research Facilities.

He became Visting Professor in Biomedical Science at University of Lincoln in 2015 where He leads the MPN/MDS molecular biology lab focusing on Philadelphia-negative MPN and abnormal pathways in MDS.

In 2014 he became the Haematology Expert Clinical Advisory Group (ECAG) Lead for the East Midland.

Editor-in-Chief


Ciro Rinaldi

University of Lincoln, Italy

Read more

Editorial Board.


Jan Jacques Michiels

Professor
Senior Internist
International Hematology and Bloodcoagulation Research Center,
Goodheart Institute and Foundation in Nature Medicine,
European Working Group on Myeloproliferative Neoplasms,
The Netherlands

William Ebomoyi

Department of Health Studies,
College of Health Sciences,
Chicago State University
USA

Jalid Sehouli

Professor, Director
Department of Obstetrics with Centre for Oncological Surgery
Head of the European Competence Center for Ovarian Cancer Campus
Universitätsmedizin Berlin Charité
Medical University of Berlin Augustenburger
Germany


Samar Masoumi-Moghaddam

Center for Immunotherapy Roswell Park Cancer Institute
Elm & Carlton Streets
USA

Diana O. Treaba

Associate Professor of Pathology Hematopathologist, Anatomic and Clinical Pathologist Director, Hematopathology Laboratories at Rhode Island Hospital and Miriam Hospital, USA

Afshin Amini

St George Hospital
The University of New South Wales
Sydney
Australia


Felicetto Ferrara

Division of Hematology and Stem Cell Transplantation Unit Cardarelli Hospital, Naples, Italy

Ayelet Shai

Oncology Department
Galilee Medical Ceneter, Nahariya
Bar Ilan Faculty of Medicie
Zefad,Israel

Augusta Silveira

Faculty of Health Sciences Fernando Pessoa University Praça 9 de Abril, Porto, Portugal


Jamal Khader

Radiation Oncologist Director, Radiation Oncology Residency Program Radiation Oncology Department, Jordan

Dr. Kadir CETINKAYA

Obstetrics and Gynecology General Surgery Ankara Oncology Education and Research Hospital Ankara, Turkey

Rongbiao Tang

Department of Radiology
Ruijin hospital, School of Medicine
Shanghai Jiao Tong University (SJTU)
China


Antonio Russo

Medical Oncology Director
Department of Oncology
A.O.U.P. "P. Giaccone" University Hospital
Designated Centres of Integrated Oncology and Palliative Care
Palermo, Italy

Dr Petar Avramovski

Specialist of internal medicine
Department of Internal medicine
Clinical Hospital-Bitola, Macedonia

Katarina Baluchova

Jessenius Faculty of Medicine in Martin
Commenius University
Slovakia


Caroline Brunetto de Farias

Laboratório de Pesquisas em Câncer
Hospital de Clínicas de Porto Alegre
Porto Alegre, Brazil

Kaiser Jamil

Professor and Honorary Director
School of Biotechnology and Bioinformatics
Mahatma Gandhi National Institute for Research and Social Action (MGNIRSA)
Hyderabad, India

Giuseppe Luigi Banna

Clinical Head
Division of Medical Oncology
Cannizzaro Hospital–Catania
Italy.


Marwa Monier Mahmoud Refaie

Faculty of medicine
Minia University
Egypt

Alfredo Addeo

Senior consultant oncologist
University Hospital of Geneva
Switzerland

Prof. Francesco Buccisano

Cattedra Di Ematologia
Univerista Tor Vergata Di Roma
Italy

In Press


Will be update soon.

Current Issue

Volume 8 Issue 2


Rare presentation of Castleman Disease with Leptomeningeal Enhancement Without a Solitary Mass: A Case Report and Literature Review

Sally LeongBrian HoTiffanie DoJames YehSarah Tomassetti

Case Report-Hematology and Medical Oncology (HMO)

undefined


Archive


Volume 8

Rare presentation of Castleman Disease with Leptomeningeal Enhancement Without a Solitary Mass: A Case Report and Literature Review

Sally LeongBrian HoTiffanie DoJames YehSarah Tomassetti

Case Report-Hematology and Medical Oncology (HMO)

undefined


Changes of serum Amyloid-A (SAA), tumor necrosis factor-a (TNF-a), c-reactive protein (CRP) and association of CRP with cystatin-c in kidney transplantation

Athina GompouDespina PerreaTheodore KaratzasAnastasia Kastania Maria RaptopoulouResearch Article

Research Article-Hematology and Medical Oncology (HMO)

undefined


Long-term progression-free survival in a patient with inoperable pancreatic cancer following image-guided stereotactic ablative radiotherapy

Maohui Yan, Zhiguang Fu Chen Liu Hongqi Li

Case Report-Hematology and Medical Oncology (HMO)

undefined


Volume 7

Combination of ultrasound-guided radiofrequency ablation with puncture and aspiration for the intrauterine treatment of fetal sacrococcygeal cystic solid teratoma: A case report

Qingguo Zou Qiong Luo Yutian Han Minyan Wang Xiaofeng Fu Shanshan LiuShanshan Liu Licheng Wang Jiang Zhu

Case Report-Hematology and Medical Oncology (HMO)

undefined


The spectrum of underlying diseases in patients with positive-Direct Antiglobulin Test

RiadAkoum MichelSaade WassimSerhal EmileBrihi

Research Article-Hematology and Medical Oncology (HMO)

undefined


A Few of Modern Therapeutic Concepts in Oncology

Daniel Gandía Cecilia Suárez

Opinion Article-Hematology and Medical Oncology (HMO)

undefined


Exceptional long term complete response to metronomic chemotherapy in advanced breast cancer

Anna Natalizia Santoro Maria Laura Iaia Valeria Sanna Alessandro Fancellu Palma Fedele

Case Report-Hematology and Medical Oncology (HMO)

undefined


Lymphopenia-what is under the term

AN Shoutko

Case Report-Hematology and Medical Oncology (HMO)

March 04, 2022


Volume 6

Challenges of oral antithrombotic therapy in breast cancer patients treated with cyclin-dependent kinase inhibitors: A case report

Jorge Illarramendi MD Nuria Aymerich MD María Herrera MD Julia Coll MD Jose Juan Illarramendi MD

Case Report-Hematology and Medical Oncology (HMO)

July 12, 2021


STAMP inhibitor Asciminib and medium-chain fatty-acid derivative AIC-47: novel therapies for chronic myeloid leukemia

Satoshi Uchiyama Haruka Shinohara SungGi Chi Rikako Tabata Yong-Mei Guo Junichiro Yuda Takaaki Ono Yosuke Minami

Review Article-Hematology and Medical Oncology (HMO)

July 15, 2021


Abdominal inflammatory myofibroblastic tumour in a 4 month old baby- A case report

Abhishek Kumar Jha Lipika Lipi Meera Luthra Kulbir Ahlawat

Case Report-Hematology and Medical Oncology (HMO)

July 23, 2021


Sister Chromatid Exchange Assay for Guiding and Improving Cancer Chemotherapy

D Mourelatos

Case Report-Hematology and Medical Oncology (HMO)

April 30, 2021


Sensory ganglionopathy mediated by autoimmunity and toxicity

Tara Kannan Adel Ekladious

Case Report-Hematology and Medical Oncology (HMO)

June 30, 2021


The role of epigenetics in post- covid adaptation

Maria Grazia Spurio

Review Article-Hematology and Medical Oncology (HMO)

June 11, 2021


The clinical case of an oncological patient affected by mandibular osteonecrosis and literature review about therapeutic alternatives

Francesca Marasciulo Giuseppe Lomurno Mario Mandalà Fausto Roila

Case Report-Hematology and Medical Oncology (HMO)

June 25, 2021


Laproscopic and robotic management of obstructive ureteral injuries: A Review

Khalid Deshmukh Gaaminepreet Singh

Review Article-Hematology and Medical Oncology (HMO)

June 30, 2021


Role of membrane transportors in cisplatin induced nephrotoxicity

Sakshi Rajput Gaaminepreet Singh

Review Article-Hematology and Medical Oncology (HMO)

June 30, 2021


Correlation between IHH molecular pathway activation and tumor location, sex, age, distant metastases, in patients with diagnosed colorectal adenocarcinoma. Experimental study

David G Symeonidis Andreas C Lazaris Adamantia Zizi-Zerbetzoglou Panagiotis P Christodoulou Nikolaos G Kavantzas Niki Asimaki Georgia-Eleni Thomopoulou

Research Article-Hematology and Medical Oncology (HMO)

January 11, 2021


Replacement of 8-MOP/UV-A treatment by UV-C irradiation for further development of Extracorporeal Photopheresis

Holger Budde Carla Marie Zwerenz Carla Barrios-Bussmann Ivan Bogeski Joachim Riggert Holger M Reichardt Tobias J Legler

Research Article-Hematology and Medical Oncology (HMO)

January 21, 2021


Melanoma incidence is still increasing in susceptible young Australians

Dr. D. Czarnecki

Letter to Editor-Hematology and Medical Oncology (HMO)

January 25, 2021


Asymptomatic COVID-19 among individuals living with diabetes: Rapid scoping review

Nwose EU Bwititi PT

Research Article-Hematology and Medical Oncology (HMO)

January 28, 2021


Kaposi’s varicelliform eruption following brentuximab vedotin chemotherapy is associated with robust anti-tumor response in an advanced mycosis fungoides patient

Zaw H. Phyo Powell Perng Sahar Soleimani Jun Kang Richard Ambinder Sima Rozati

Case Report-Hematology and Medical Oncology (HMO)

March 31, 2021


Disseminated NK-T Cell Lymphoma Initially Suspected by the Presence of Circulating CD45 bright/CD7 negative NK cells

David Azoulay Eugene Dementiev Noa Gross Revital Saban Hananya Vaknine Luiza Akria Hector I Cohen Netanel Horowitz

Case Report-Hematology and Medical Oncology (HMO)

March 31, 2021


Volume 5

Impact of Lymphopenia on COVID-19 infection Severity Single-center experience

Elhassadi E Morton F Hourigan A McDonald L Elstead C

Research Article-Hematology and Medical Oncology (HMO)

September 03, 2020


Flow cytometry analysis in atypical aggressive NK leukemia/lymphoma in a 44 year old Caucasian male: a case report

Vlad-Andrei Cianga Anne-Camille Faure Jérémie Stagnara Lauren Rigollet Pascale Flandrin-Gresta Jérôme Cornillon Denis Guyotat Lydia Campos Catafal Carmen-Mariana Aanei

Case Report-Hematology and Medical Oncology (HMO)

September 14, 2020


Higher prevalence of arterial vs venous disorders in patients with congenital Prekallikrein deficiency

Antonio Girolami Silvia Ferrari Bruno Girolami

Mini Review-Hematology and Medical Oncology (HMO)

December 17, 2020


Hemoglobin and anemia in COVID19 patients

Eloisa Urrechaga Saioa Zalba Isabel Otamendi María Ascensión Zabalegui Arkaitz Galbete Eva Ongay Mónica Fernandez Jose Antonio García-Erce

Research Article-Hematology and Medical Oncology (HMO)

December 28, 2020


Prognostic factors and therapeutic perspectives of meningeal carcinomatosis in patients with breast cancer: A case report and review of the literature

Francesca Marasciulo Marialuisa Meacci Guglielmo Fumi Luca Marcomigni Roberta Porreca Fausto Roila

Case Report-Hematology and Medical Oncology (HMO)

December 28, 2020


The influence of immigration on the latitude gradient of melanoma in Australia

Dr. D. Czarnecki

Research Article-Hematology and Medical Oncology (HMO)

December 31, 2020


Cytotoxic potential of sponge extracts from Mauritius Waters on human cancer cell lines

Prerna Roy Avin Ramanjooloo Jay Rovisham Singh Doorga Girish Beedessee Thierry Cresteil Rob WM Van Soest Daniel EP Marie

Research Article-Hematology and Medical Oncology (HMO)

May 08, 2020


The importance of distinguishing Mycoplasma pneumoniae-induced rash and mucositis (MIRM) and Stevens-Johnson syndrome in a clinical setting

Dr Roman Pillay Prof. Suran L Fernando

Short Communication-Hematology and Medical Oncology (HMO)

May 09, 2020


Pilot Study Assessing Distressors Affecting Patients with Cancer Using the Distress Thermometer Screening Tool

Rana Yamout Jeanny Aragon-Ching Mary Abed Al Ahad Ali Taher Antoine Finianos

Review Article-Hematology and Medical Oncology (HMO)

May 25, 2020


P2Y12 inhibitors during and after acute coronary syndrome, where do we stand in 2020?

Noé Corpataux Marco Valgimigli

Review Article-Hematology and Medical Oncology (HMO)

July 30, 2020


Unclassifiable B-cell lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma in an AIDS patient. Report of a case and literature review

Valerga M Corti M Bruni G Maiolo E Campitelli A Narbaitz M Metrebian F

Case Report-Hematology and Medical Oncology (HMO)

August 07, 2020


A rare case of urinary retention in an adult due to a primary penile Tumor

Marcelo Di Gregorio Marie Cécile Nollevaux Michaël Dupont Pr Francis Lorge Pr.Lionel D’Hondt

Case Report-Hematology and Medical Oncology (HMO)

April 09, 2020


Parent Educational Intervention Program for Improving Parental Knowledge, Self-efficacy and Health Related Quality of life in Children with Sickle Cell Disease using Smartphone Technology: A Randomized Controlled Trial

Yusra Al Nasiri Eufemia Jacob Eunice Lee Adey Nyamathi Mary-Lynn Brecht Wendie A Robbins Adhra Al Mawali

Research Article-Hematology and Medical Oncology (HMO)

April 27, 2020


Arg304Gln (FVII Padua) coagulation disorder in a patient with Down Syndrome (trisomy 21): a remarkable observation from Argentina

Antonio Girolami Maria Silvia Farhat Cecilia Hayward Silvia Ferrari Eleonora B. Rossi

Research Article-Hematology and Medical Oncology (HMO)

April 27, 2020


Clinical and cytogenetic features of Moroccan patients with primary myelodysplastic syndrome

Ahnach Maryame

Research Article-Hematology and Medical Oncology (HMO)

April 28, 2020


Hematological and Immunological parameters in apparently healthy people in Ethiopia: Systematic review and meta-analysis

Ephrem Awulachew Kuma Diriba Sara Anberbir

Research Article-Hematology and Medical Oncology (HMO)

April 29, 2020


First report of pembrolizumab extravasation

Elena Bolzacchini Monica Giordano

Letter to Editor-Hematology and Medical Oncology (HMO)

November 21, 2019


The potential significance of two coagulation defects: Prekallikrein Deficiency and Arg304Gln (FVII Padua) frequently found among African-Americans

Girolami Antonio Ferrari Silvia

Letter to Editor-Hematology and Medical Oncology (HMO)

January 13, 2020


Inflammation and venous thromboembolic disease

Pavel Poredoš

Letter to Editor-Hematology and Medical Oncology (HMO)

January 17, 2020


Possible roles of CD73 (ecto-5'-nucleotidase) and clinical significance in metastasis human cancer

Marco Antonio Lacerda-Abreu José Roberto Meyer-Fernandes

Review Article-Hematology and Medical Oncology (HMO)

February 17, 2020


The high prevalence of Prekallikrein deficiency among African Americans deserves further studies

Antonio Girolami Silvia Ferrari Elisabetta Cosi Bruno Girolami

Letter to Editor-Hematology and Medical Oncology (HMO)

February 24, 2020


Volume 4

Correlation of cytomorphology and histopathology in the diagnostic process of myeloid malignancies

Laura Engelbrecht Katharina S Götze Kristina Schwamborn Catharina Müller-Thomas Tamara Alpermann Nicolas Bonadies Myriam Legros Johanna Flach Thomas Pabst Yara Banz Ulrike Bacher

Research Article-Hematology and Medical Oncology (HMO)

October 14, 2019


Detecting JAK2 mutations in myeloproliferative neoplasms: can you please all the people all of the time?

Stephen E. Langabeer

Commentary-Hematology and Medical Oncology (HMO)

November 01, 2019


Considering temporal dimension for NSCLC medical management?

Focan C Bourhaba M Graas MP Levi F

Opinion Article-Hematology and Medical Oncology (HMO)

November 01, 2019


Early development of bone marrow failure following severe congenital thrombocytopenia in patient with Noonan syndrome – case report and review of literature

Lucie Sramkova Manuela Germeshausen Karolina Mrhalova Tomas Kuhn Marketa Vlckova Michaela Nemcikova Vit Campr Tomas Tlaskal Tibor Klein Jan Stary

Research Article-Hematology and Medical Oncology (HMO)

November 07, 2019


The challenge of Inotuzumab ozogamicin treatment as “bridge to transplant” in relapsed/refractory B cell-acute lymphoblastic leukemia

Radici Vera De Marchi Roberta Sperotto Alessandra Cerno Michela Geromin Antonella Battista Marta Lisa Candoni Anna Filì Carla Zannier Maria Elena Lazzarotto Davide Simeone Erica Dubbini Maria Vittoria Rabassi Nicholas Facchin Gabriele Fanin Renato Patriarca Francesca

Case Report-Hematology and Medical Oncology (HMO)

November 11, 2019


A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay

Van Helden J Evliyaoglu O Dreßen D Weiskirchen R

Research Article-Hematology and Medical Oncology (HMO)

November 11, 2019


TP53 status in Mantle Cell Lymphoma (MCL) - A 10-year single center experience

Elhassadi E Hennessy B Kumar S Swan D Lee EBarrett N Doyle M Shilling C Catherwood M

Research Article-Hematology and Medical Oncology (HMO)

July 19, 2019


Prevention of hepatitis B virus reactivation in lymphoma patients

Blanca Sanchez-Gonzalez Montserrat Garcia-Retortillo Teresa Murcia Laia Martinez Ricard Sola Francesc Garcia-Pallarols Antonio Salar

Letter to Editor-Hematology and Medical Oncology (HMO)

July 22, 2019


Fractal dimension as tool for vascular diagnosis in health

José Guedes da Silva Júnior Iasmyn Dayanne Santos do Nascimento Sílvia Renata Ribeiro Araújo Camila Geórgia Silva Nascimento Maria Eduarda Barbosa de Moraes Layslla Caroline Araújo Almeida Mônica Nayara Batista Barbosa Hallysson Douglas Andrade de Araújo José Adelson Alves do Nascimento Júnior Victor Felipe da Silva AraújoTalyta Valéria Siqueira do Monte

Research Article-Hematology and Medical Oncology (HMO)

July 26, 2019


Synchronous squamous cell carcinoma of the lung and type AB thymoma - is effective radical treatment possible?

Magdalena Knetki-Wróblewska Małgorzata Szołkowska Tadeusz Orłowski Dariusz M Kowalski

Case Report-Hematology and Medical Oncology (HMO)

September 30, 2019


The impact of faulty prostatic phylogeny and the development of benign prostatic hyperplasia

Roper WG

Mini Review-Hematology and Medical Oncology (HMO)

September 30, 2019


Progress in radiotherapy and expression of PD-L1 in esophageal cancer

Xiangyong Liu Ying Sun

Review Article-Hematology and Medical Oncology (HMO)

March 29, 2019


A new insight into apheresis platelet donation by sickle cell trait carriers: evidences of safety and quality

Suzanna Araujo Tavares Barbosa Denise Menezes Brunetta Sérgio Luiz Arruda Parente Filho Guilherme de Alencar Salazar Primo Franklin José Candido Santos Luciana Maria de Barros Carlos Naliele Cristina Maia de Castro Juan Daniel Zuñiga Pro Elizabeth De Francesco Daher

Research Article-Hematology and Medical Oncology (HMO)

June 10, 2019


Unresectable retrovesical synovial sarcoma treated by chemotherapy and radiotherapy: A rare case report

Mohammed Afif Saoussan Kharmoum Youssef Omor Jihane Khalil Mohamed Elhfid

Case Report-Hematology and Medical Oncology (HMO)

June 11, 2019


Gastrointestinal side effects of immune checkpoint inhibitors: new topic for gastroncologists

Semra Paydas

Review Article-Hematology and Medical Oncology (HMO)

June 13, 2019


Neo-adjuvant chemo-radiation therapy in T4 resectable oral cavity cancer

Cheemala Sushmitha Barbosa Geeta S Narayanan Ganesh MS Vasu Reddy Bhaskar Vishwanathan Sanjeet Kumar Mandal Sowmya Narayanan Shadhidhar V Karupaiah Manjunath

Research Article-Hematology and Medical Oncology (HMO)

June 27, 2019


Nanoparticles for hematologic diseases detection and treatment

Tania Limongi Francesca Susa Valentina Cauda

Review Article-Hematology and Medical Oncology (HMO)

June 28, 2019


Treatment of advanced stage classical Hodgkin lymphoma: a pathway through the maze

Hildyard C AT Vora SM Collins GP

Review Article-Hematology and Medical Oncology (HMO)

December 21, 2018


Genetic factors and Waldenström's macroglobulinemia: Systematic review and meta-analysis

Alejandro Santos-Lozano Jesús Rueda-González Juan Martín-Hernández Jorge Serna-Molpereces Carlos Cristi-Montero Carmen Fiuza-Luces Carlos Baladrón José Pinto-Fraga Nuria Garatachea María Teresa Cedena Joaquín Martínez-López Alejandro Lucia

Research Article-Hematology and Medical Oncology (HMO)

December 27, 2018


Multicentric Castleman Disease in the Uncontrolled Diabetic

Jessica Y Chambers MD

Case Report-Hematology and Medical Oncology (HMO)

January 25, 2019


Harmful Health Effects of the Deepwater Horizon Gulf Oil Spill Exposure among People Who Participated in the Cleanup Operations

Mark A D’Andrea G Kesava Reddy

Case Report-Hematology and Medical Oncology (HMO)

January 25, 2019


Pancytopenia due to graft versus host disease post liver transplantation: A case report

Uzoka C Tzvetanov IG Patel P Benedetti E Rondelli D

Case Report-Hematology and Medical Oncology (HMO)

January 31, 2019


The detection of colorectal adenoma is determined by the level of plasma mSEPT9

Lele Song Na He Yuan Gong

Case Report-Hematology and Medical Oncology (HMO)

January 31, 2019


Volume 3

Gender specific aspects in patients with mantle cell lymphoma undergoing rituximab-based therapy – what role does gender play?

Wolfgang Lamm Barbara Kiesewetter Philipp Bauer Georg Jeryczynski Markus Raderer

Research Article-Hematology and Medical Oncology (HMO)

October 01, 2018


Dysregulation in Cortisol Diurnal Activity among Myeloproliferative Neoplasms Cancer Patients

Maricarmen Vizcaino Jennifer Huberty Linda Larkey J Heidi Kosiorek Krisstina Gowin Ryan Eckert Ruben A Mesa

Research Article-Hematology and Medical Oncology (HMO)

October 11, 2018


The use of meditative movement as a non-pharmacologic approach in hematological cancer patients: A systematic review of the literature

Ryan Eckert Jennifer Huberty Linda Larkey Lisa Marks Ruben Mesa

Research Article-Hematology and Medical Oncology (HMO)

October 18, 2018


Pembrolizumab for platinum refractory small cell carcinoma of the prostate, case report

Salhab M Donahue M Walsh W

Case Report-Hematology and Medical Oncology (HMO)

October 29, 2018


The mutational landscape of chronic neutrophilic leukemia: case report and literature review

Stephen E. Langabeer Ezzat Elhassadi

Case Report-Hematology and Medical Oncology (HMO)

November 01, 2018


Composite splenic marginal zone lymphoma and mantle cell lymphoma with p53 deletion and tetraploidization

David Azoulay Eugene Dementiev Luba Trakhtenbrot Netanel Horowitz Tamar TadmorLuiza Akria

Case Report-Hematology and Medical Oncology (HMO)

November 02, 2018


What is the role of surgery in stage III NSCLC in the era of immunotherapy?

Addeo A Bianchi D Minervini F

Mini Review-Hematology and Medical Oncology (HMO)

June 25, 2018


Overall Survival is not the only Endpoint to Measure Clinical Relevance

Picardi C Di Maio M Addeo A

Commentary-Hematology and Medical Oncology (HMO)

June 29, 2018


Integrating New Treatment Options into the Management of Adult ITP

James Granfortuna

Review Article-Hematology and Medical Oncology (HMO)

August 13, 2018


Fine needle aspiration cytology guided by ultrasound of suspicious axillary lymph nodes in breast cancer patients

Waldeir de Almeida Junior Alexandre de Almeida Barra Henrique Moraes Salvador Silva Marco Antonio Dias Filho Henrique Lima Couto Breno Bernardes de Souza Belo Horizonte

Research Article-Hematology and Medical Oncology (HMO)

September 17, 2018


Kaposi Sarcoma among non-HIV patients with hematological malignancy: An unusual reality

Giamal Edin Gmati Farhan Khalid Abdullah Abdulaziz Alharbi Muhammad Al-Nahdi Ahmed Alaskar

Case Report-Hematology and Medical Oncology (HMO)

September 24, 2018


Severe aplastic anemia during osimertinib treatment in a non-small cell lung cancer patient harboring EGFR T790M mutation

Seo Ree Kim Jihyun Han Jae-Ho Yoon Jeong-Oh Kim Jin hyoung Kang

Case Report-Hematology and Medical Oncology (HMO)

September 27, 2018


Unusual case of IgE multiple myeloma: case report

Malary Mani Wen Fan Katherine Hawkins

Case Report-Hematology and Medical Oncology (HMO)

March 23, 2018


Papillary thyroid microcarcinoma: active surveillance in the follow-up of persistence structural disease

P Bellitti A Carbone D Cito R Bruno

Letter to the Editor-Hematology and Medical Oncology (HMO)

March 26, 2018


Creation of anticancer drugs employing metal-containing macromolecules

Charles EC Jr Michael RR

Review Article-Hematology and Medical Oncology (HMO)

April 20, 2018


Is there any advantage from continuation of trastuzumab beyond progression in metastatic her positive gastric cancer? report of two cases and literature review

Rachid Tanz Tarik Mahfoud Ilyas El Alami Aziz Bazine Hassan Errihani Mohamed Ichou

Case Report-Hematology and Medical Oncology (HMO)

April 20, 2018


Synthesis of organotin polymers from 2-ketoglutaric acid and their ability to inhibit the growth of human cancer cell lines

Charles E. Carraher Jr Michael R. Roner Dhruvin Patel Lindsey C. Miller Alisa Moric-Johnson Paul Slawek Francesca Mosca Jessica Frank

Research Article-Hematology and Medical Oncology (HMO)

February 28, 2018


Dietary iodine intake, thyroid diseases and the prevalence of papillary carcinoma (PTC)

George Zhu

Review Article-Hematology and Medical Oncology (HMO)

February 17, 2018


Differential DNA damaging effects of genotoxic agents from chewing tobacco and gutka

Azad Kumar Nilesh Kumar Sharma

Research Article-Hematology and Medical Oncology (HMO)

March 09, 2018


Image guided robotic interstitial brachytherapy, a new innovative treatment for malignancies

Bhaskar Vishwanathan Sanjeet Kumar Mandal Rishabh Kumar HV Ramprakash

Research Article-Hematology and Medical Oncology (HMO)

February 27, 2018


Volume 2

Robot-Assisted Retroauricular Neck Surgery in Head and Neck Cancers

Muhammet Recai Mazlumoglu

Research Article

December 04, 2017


Gemcitabine-vinorelbine-prednisolone combination in cases with lymphoma: retrospective analysis

Semra Paydas Emine Kilic Bagir Melek Ergin

Research Article

December 18, 2017


Breast cancer associated with paraneoplastic dermatomyositis (DM); case report

Abeer Hussien Anter Samir Taha Alfotih

Case Report

December 26, 2017


Perivascular niches as points of the utmost expression of tumor microenvironment

Annovazzi Laura Mellai Marta Bisogno Ilaria Spatola Alessandra Bovio Enrica Cassoni Paola Casalone Cristina Schiffer Davide

Research Article

December 29, 2017


Archaeal genome and cancerogenesis

Stupar Milanko Stefanovic Slavica

Review Article

December 29, 2017


Diabetes Mellitus Is Associated with Hepatocellular Carcinoma: A Retrospective Study in Southwest China

Yi-Shu Tang Lang Wu Fang Cui

Research Article-Hematology & Medical Oncology (HMO)

JuLY 14, 2017


The association between oral anaerobic bacteria and acute myeloid leukemia

Mesut Öğrendi

Research Article-Hematology & Medical Oncology (HMO)

July 27, 2017


The design and implementation of caloric restriction for oncology research (CaReFOR): Is starving cancer cells in the clinical realm feasible?

Brittany A. Simone Pramila Rani Anne Kevin Ko Mak Sarich Kimberly Strickland Daniel Monti Adam C. Berger Nicole L. Simone

Research Article-Hematology & Medical Oncology (HMO)

October 09, 2017


Angiosarcoma: A rare cause of splenomegaly

Thiagarajah Balamurugan Shaun R. Preston Izhar N. Bagwan

Case Report-Hematology & Medical Oncology (HMO)

October 23, 2017


White rodlike crystals in multiple myeloma cells

Juan Zhang Mingyong Li Yuan He

Case Report-Hematology & Medical Oncology (HMO)

October 26, 2017


How does obesity influences anatomopathologic features in radical prostatectomy specimen? Importance of body fat mass distribution

Morán E Budía A Martínez-Sarmiento M Broseta E Cámara R Boronat F

Research Article-Hematology & Medical Oncology (HMO)

October 26, 2017


Bevacizumab in high grade glioma: Is there a subgroup that benefits?

George Rigakos Anastasios Kyriazoglou Anastasia Vernadou Sotiris Papadopoulos Evangelia Skarpidi Panagiotis Nomikos Constantinos Dardoufas George Nassioulas George Kouvatseas Olympia Spyri Stefanos Labropoulos Evangelia Razis

Research Article-Hematology & Medical Oncology (HMO)

June 15, 2017


Myeloproliferative neoplasms, thrombosis and paroxysmal nocturnal hemoglobinuria: Is this triad more frequent than we thought?

Gaidano V Geuna M Cignetti A Carnuccio F Bernabei P Santoro N Saglio G P Sivera

Case Report-Hematology & Medical Oncology (HMO)

June 19, 2017


Application of embryonic models for elaboration of anti-carcinogenic preparations of desired action

Aminov AV Mekhtiev AA

Research Article-Hematology & Medical Oncology (HMO)

June 19, 2017


Un exceptional cause of lymphocytic colitis: Brucellosis

Raida Ben Salah Faten Frikha Rim Kallel Boudawara T Bahloul Z

Case Report-Hematology & Medical Oncology (HMO)

June 19, 2017


Biology of DNMT3 and LSD1 inhibition in acute myeloid leukemia (AML)

Samantha Messina

Mini Review-Hematology & Medical Oncology (HMO)

June 23, 2017


Traditional Chinese medicine Tongxinluo stimulates coronary collateral growth in a pig myocardial infarction model

Gao-Feng Wang Sen Ye Jian-Guo Cui Naiquan Yang Ke Xu Shu-Hua Zhang Chun-Jian Li

Research Article-Hematology & Medical Oncology (HMO)

June 26, 2017


Long-term follow-up of curcumin treated MGUS/SMM patients – an updated single centre experience

Terry Golombick Terrence H. Diamond Arumugam Manoharan Rajeev Ramakrishna

Letter to Editor-Hematology & Medical Oncology (HMO)

April 29, 2017


Ganoderma lucidum on the inhibition of colorectal cancer

Hong Ye Alfred Bennett Jenson

Review Article-Hematology & Medical Oncology (HMO)

May 09, 2017


Follow-up examinations performed by radiation oncologists after radiotherapy in Japan

Osamu Tanaka Eiichi Yama Hironori Ichihashi Yuzo Yamada Junichi Ando Takayoshi Iida

Research Article-Hematology & Medical Oncology (HMO)

May 22, 2017


A rare case of autoimmune pancytopenia (AIP) preceded by refractory anemia: Possible involvement of cytomegalovirus (CMV) infection in pathogenesis

Nobuo Takemori Goro Imai Hirobumi Matsumura Toshio Fukuda Masaru Kojima

Case Report-Hematology & Medical Oncology (HMO)

May 29, 2017


Immunomodulatory drugs and their therapeutic effect in hematological malignancies through cereblon

Ota Fuchs

Review Article-Hematology & Medical Oncology (HMO)

May 31, 2017


What-about-the-neutrophils-phenotypes

Fernando Marcos Rodriguez Ivon Teresa Clara Novak

Review Article-Hematology & Medical Oncology (HMO)

May 31, 2017


Novel treatment of pulmonary embolism in a patient with sickle cell disease

Marium Husain Payal Desai Peter Bittenbender Eric Kraut Raymond Magorien

Case Report-Hematology & Medical Oncology (HMO)

March 03, 2017


Metastatic small cell carcinoma of the prostate in an octogenarian with significant response to first-line chemotherapy

Anthony Wood Nabil Adra Liang Cheng Roberto Pili

Case Report-Hematology & Medical Oncology (HMO)

March 07, 2017


Update on NSCLC tissue acquisition, processing, and profiling in the molecular age

Anna J. Conterato Adam R. Belanger Lonny B. Yarmus Jason A. Akulian

Review Article-Hematology & Medical Oncology (HMO)

March 11, 2017


A pilot study of chemotherapy and traditional plant medicine in hematology malignancy: Report of thirty-four cases

George Zhu Saboor-Yaraghi AA Dharmadhikari D Baer J

Research Article-Hematology & Medical Oncology (HMO)

March 22, 2017


Circumcision of children with hemophilia in local places

Goksel Leblebisatan

Commentary-Hematology & Medical Oncology (HMO)

March 22, 2017


Multiple electrode aggregometry in thrombocytopenic haemato-oncologic patients – Influence of haematologic variables

Elin Netland Opheim Torunn Oveland Apelseth Simon J. Stanworth Geir Egil Eide Tor Hervig

Research Article-Hematology & Medical Oncology (HMO)

March 27, 2017


Clinical response in osteogenic sarcoma patients treated with ultra-dilute medicines

Prasanta Banerji Pratip Banerji

Case Report-Hematology & Medical Oncology (HMO)

January 14, 2017


Clinical Utility of Circulating Tumor Cells – A Clinician’s Current View

Tar Choon AW

Research Article-Hematology & Medical Oncology (HMO)

January 23, 2017


Successful treatment with lenalidomide dexamethasone for second relapse of a patient with non-secretory multiple myeloma with extramedullary liver plasmacytomas: A case report

Gavriatopoulou Maria Terpos Evangelos Roussou Maria Migkou Magdalini Ntanasis-Stathopoulos Ioannis Kastritis Efstathios Meletios Athanasios Dimopoulos

Case Report-Hematology & Medical Oncology (HMO)

February 06, 2017


Utilization of splanchnic nerve radiofrequency lesioning for pain control in cholangiocarcinom

Brian Kahan

Short Communication-Hematology & Medical Oncology (HMO)

February 11, 2017


An overview on the role of autophagy in cancer therapy

Daniela Grácio Fernando Magro Raquel T. Lima Valdemar Máximo

Review Article-Hematology & Medical Oncology (HMO)

February 18, 2017


Volume 1

Brush border enzymuria originating from proximal renal tubules as sifted test in patients with psoriatic arthritis

Dejan Spasovski

Research Article-Hematology & Medical Oncology (HMO)

November 14, 2016


Preimplantation HLA typing for stem cell transplantation treatment of congenital and acquired bone marrow failures

Anver Kuliev Svetlana Rechitsky

Research Article-Hematology & Medical Oncology (HMO)

November 17, 2016


Ratios of selected chemical element contents in prostatic tissue as markers of malignancy

Vladimir Zaichick Sofia Zaichick

Research Article-Hematology & Medical Oncology (HMO)

November 26, 2016


The effect of the eccentric loading on the components of the spine

Samir Zahaf Bensamine Mansouri Abderrahmane Belarbi Zitouni Azari

Research Article-Hematology & Medical Oncology (HMO)

November 28, 2016


The characteristics of breast cancer in geriatric patients

Aybala Ağaç Ay Haluk Ulucanlar Selçuk Misirligil Ahmet Alyanak Saadet Akturan

Research Article-Hematology & Medical Oncology (HMO)

November 28, 2016


Hypersensitivity reactions to enoxaparin and unfractionated heparin in a pregnant woman with gestational thrombocytopenia: A case report

Fahad A S Al-Eidan Nourah Al-Qhtani Areej F Alsubaie Badria M Al-Nouh

Case Report-Hematology & Medical Oncology (HMO)

December 29, 2016


First report of homozygous factor VII Padua (Arg304Gln) defect in a family from Argentina

Girolami Antonio Arias Mirta Sueldo Emanuel Scoles Graciela Ferrari Silvia Lombardi Anna Maria

Research Article-Hematology & Medical Oncology (HMO)

July 04, 2016


The European clinical, molecular and pathological (Euro cmp → CMP) and WHO-CMP criteria of the myeloproliferative disorders 1940-2008 and myeloproliferative neoplasms 2008-2015

Jan Jacques Michiels Hendrik De Raeve

Review Article-Hematology & Medical Oncology (HMO)

July 16, 2016


Benign fibrous histiocytoma, case report

Monica D’Amato Gutiérrez Natalia Andrea Valencia Zuluaga Andrea Parra Buitrago David Andrés Espinal Botero

Case Report-Hematology & Medical Oncology (HMO)

August 22, 2016


Personalised/precision medicine

Shaun R. McCann

Short Communication-Hematology & Medical Oncology (HMO)

August 27, 2016


Downregulating oncogenic receptor: From bench to clinic

George Zhu Ali-Akmbar Saboor-Yaraghi Yosef Yarden Joana Santos Neil JC

Review Article-Hematology & Medical Oncology (HMO)

October 16, 2016


Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal Cells

Leland Metheny III Saada Eid Karen Lingas Jane Reese Howard Meyerson Alexander Tong Marcos de Lima Alex Y. Huang

Research Article-Hematology & Medical Oncology (HMO)

October 20, 2016


External Databases & Indexes


  • WorldCat
  • Crossref
  • Google scholar
  • Pubmed*
  • NSD*

Submit Manuscript


Hematology journal welcomes direct submissions from authors: Attach your word file with e- mail and send it to submissions@oatext.com alternatively to editor.hmo@oatext.com

Special Issues


Stem Cells in Hematology


  • Editor Affiliation:

    Dr. Felicetto Ferrara
    Division of Hematology and Stem Cell Transplantation Unit
    Cardarelli Hospital
    Italy

Submission date: October 30, 2018
Publication date: November 15, 2018

Description of the Special Issue: Hematopoietic stem cells (HSCs) focus on molecular genetic mechanisms that regulate differentiation, self-renewal, and aging. Hematopoietic precursors are a useful model for adult stem cells in general for 2 reasons. First, they are essential, producing not only all erythroid, myeloid and lymphoid cells, but natural killer cells and mast cells; and, they produce the macrophages found in liver, lung, bone, brain, and other tissues. Second, they are a well-defined example of self-renewing and differentiating cells that illustrate methods applicable to other stem cell systems. Because differentiated cells turn over continually, constant stem cell proliferation is necessary. In fact, partial proliferative exhaustion can explain losses with age in the many tissues in which repair and function depend on regeneration from adult precursor cells. In general, any impairment of stem cell function with age would reduce health in many biological systems. Conversely, any improvement of stem cell function with age could prolong health in many biological systems.

Submit manuscript to: editor.hmo@oatext.com, editor@hematologyresearch.info


  • Thrombosis and Hemostasis in Surgery


Editor Affiliation:

Dr. Ciro Rinaldi
Lincoln University
England

Submission date: October 30, 2018
Publication date: November 15, 2018

Description of the Special Issue: This special issue on Thrombosis & Hemostasis focuses on challenges related to hemostatic and thromboembolic complications in surgery or trauma. Multiple factors contribute to perioperative bleeding or thromboembolic risk. These factors might be related to the individual patient (e.g., bleeding disorders, cancer, or developmental hemostatic changes in pediatric patients), to anticoagulant medication or complications such as heparin-induced thrombocytopenia (HIT), or to inherent risks of a particular surgical procedure or affected organ (e.g., hepatobiliary surgery or renal transplantation). All of these factors can have a profound effect on expected outcomes.

Submit manuscript to: editor.hmo@oatext.com, editor@hematologyresearch.info

Publication Charges


Hematology and Medical Oncology is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Hematology and Medical Oncology are USD 2560.

Frequently Asked Questions (FAQs)

Why are your charges set at these levels?

All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

  • Recover capitalization costs;
  • Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
  • Bend the publication-charge cost downward over time.

Who will pay the APC?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

  1. Wire/Bank transfer
  2. Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after  processing of the manuscript.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Withdrawal Charges

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.

For Authors


Guidelines for Authors

In general the Manuscripts are classified in to following groups based on the criteria noted below. The author(s) are encouraged to request a particular classification upon submitting (please include this in the cover letter); however the Editor and the Associate Editor retain the right to classify the manuscript as they see fit, and it should be understood by the authors that this process is subjective to some degree. The chosen classification will appear in the printed manuscript above the manuscript title.

1. Editorial

  • Written by the OA Text Editors, Associate Editors, or Invited Guest Editors on a variety of subjects of interest to the Journal readers
  • Typically shorter than one page

2. Letter to the Editor

  • Submitted by the Reader
  • Supports, refutes, or adds relevant information related to a previously published article
  • Authors correcting their own work or responding to a critique of their article by a reader(s)
  • An abstract is not required.
  • The letter should not be divided into sections.
  • The letter will undergo peer-review similar to other articles.

3. Commentary

  • Authors suggestion (scope is open to areas beyond science/technology)
  • Reviewers recommendation
  • Represents the “perspective” or “opinion” or “hypothesis” of the author(s)
  • Amount of original data is minimal, but corroborative literature data encouraged
  • Format: Does not follow the outline of Introduction, Materials/Methods, Discussion/Conclusions, and References

4. Review

  • Authors suggestion
  • Topic is relatively broad in scope
  • Review article should be on topic which is of interest to a wide readership.
  • Review articles should have a comprehensive coverage of a topic in clear and lucid language with representative figures and images.
  • Represents an overview of published information and data from many authors and sources
  • Does not contain original data (to any great extent)
  • Abstract and keywords are must
  • Usually includes a large number of references

5. Research

  • Follows the outline of Introduction, Materials/Methods, Discussion/Conclusions, and References
  • Supported by significant and relevant amount of data
  • Data should have been developed by the author(s)
  • Conclusions are based primarily on the data presented and compared to the published literature

6. Technology/Application (or Case Studies)

  • Describes a particular technology or application
  • Surgical techniques, new instruments, technical innovations
  • Contains original data generated in the process of developing the technology or in support of the application
  • Supported by a significant amount of data
  • May follow the outline of Introduction, Materials/Methods, Discussion/Conclusions, and References
  • Does the article impress upon the readers a new process/ or technology?
  • Case Studies- detailed description with data of the specific implementation of an application or the solution to a given practical problem

7. Case Series

  • The Case Series section of OA Text reports a series of 2-6 similar cases.
  • The cases should be unusual and give unique perspective on disease presentation, pathogenesis, diagnosis, treatment and treatment side effects.
  • The cases should address a challenging diagnostic and/or therapeutic problem with possible solutions to help and treatment side effects.
  • The case should address a challenging diagnostic and/or therapeutic problem with possible solutions to help clinician's in managing these cases much more effectively.
  • Case series must be accompanied with comprehensive review of literature.
  • Abstract is required.

8. Case Reports

  • Case Reports must provide an original description of previously unreported entity or report new presentation of a known disease or a new perspective of case which poses a diagnostic and therapeutic challenge.
  • Case Reports should include a comprehensive review of similar cases and state the differences between present case and previous cases.
  • Case reports should be accompanied by clinical, radiological and pathologic images.

9. Case in Images

  • For 'Case in Images' section , the manuscript must meet all the criteria of a case report given above with the difference that 10-25 figures can be submitted for this section (Case Report can have maximum of 7 figures).
  • The figures may include clinical images, radiology images (USG, CT, MRI, PET, SPECT etc.), pathology images (histopathology, cytopathology, hematopathology) or a series of images of a procedure or event.

10. Clinical Images

  • Clinical Images section includes clinical images, diagnostic or investigative images especially images in radiology, endoscopy, pathology and cytopathology.
  • The images should be accompanied by brief history and case discussion followed by conclusion.
  • Abstract is not required.
  • The Clinical Images will undergo peer review similar to other articles.

11. Policy Bridge

  • Articles focused on bridging scientific knowledge with policy issues, policy options, or policy analysis.

12. Conference Proceedings

  • This section includes the papers presented in the conference usually published in a volume.
  • It may be months before such information is published as a journal article, or it may never be published.

13. Announcements

  • OA Text publishes announcements of conferences, meetings, seminars, symposia, courses, and other items. The announcements should be less the 150 words. They must be accompanied by name, address and email of a contact person.

OA Text also welcomes Special Issues, a set of related articles addressing themes or projects of broad interest, typically 4–10 articles in each group, usually including a synthesizing Commentary. Special Issues may fall within a single knowledge domain or be cross-listed under two or more domains; in either case, a single Editor-in-Chief will be responsible for the entire Special Feature. For more information, see our Special Issues informational page.

For detailed information on structure and formatting for each article type, please see our Manuscript Preparation guidelines.

Supporting material that cannot be included, and which is not essential for inclusion, in the full text of the manuscript, but would nevertheless benefit the reader. It should not be essential to understand the conclusions of the paper, but should contain data that are additional or complementary and directly relevant to the article content.

We encourage authors to include supplementary information with their submissions whenever appropriate; for example, when the amount of material is too great to warrant inclusion in the main body of the paper, or when the material is in a format that cannot be represented in print (i.e. audio, video, three-dimensional representations, and other rich media as well as additional figures and tables). Supplemental material provides additional information that enhances the main text and is directly referenced within the text, but is not critical to its assertions. Please note that atomic co-ordinates used to create molecular models described in a manuscript, unless deposited in a publicly available database, must be made available as Supplementary data.

Although we do not limit the number or type of supplemental material items authors may include, we do require that they provide a relevant and useful expansion of the article, and that they are as well described as are figures and tables included within the body of the article. Good metadata of this material are key to discoverability and usefulness.

For detailed information on formatting and submitting supplementary information, please see our guidelines on Supplemental Material & Data.

Major Datasets

A condition of publication in a OA Text journal is that authors are required to make materials, data and associated protocols promptly available to others without undue qualifications. Data sets must be made freely available to readers from the date of publication, and must be provided to editors and peer-reviewers at submission, for the purposes of evaluating the manuscript.

An inherent principle of publication is that others should be able to replicate and build upon the authors’ published claims. Therefore, we require that all major Data sets must be made freely available to readers from the date of publication, and must be provided to editors and peer-reviewers at submission, for the purposes of evaluating the manuscript, unless there are clear reasons to restrict access. Datasets should be archived in an appropriate, subject-specific public archive, or in an institutional repository. The Directory of Open Access Repositoriesprovides a searchable list of over 2,000 OA repositories.

For more information, please see our guidelines on Supplemental Material & Data.

Requirements for Submission

Submissions to OA Text must meet the following requirements to be considered for publication:

  • The submission represents work that has not been published or submitted for publication elsewhere.
  • The research carried out needs to be original and the data needs to be useful to other researchers. (we agree that it is not in our power to predict which submissions will be useful, hence we will be accepting all kinds of submissions inititally, with the hopes of learning and ignoring those submissions that are not useful) An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. The article should present the results of scientific research and the results should be repeatable.
  • Futile hypothesis and failed experiments need to have a sound reasoning behind their results.
  • The assurance that the experiments, statistics, and other analysis are performed to a high technical standard, are repeatable and should be described in full detail.
  • Conclusions and discussions (if any) are presented in clearly explained avoiding ambiguity and are supported by the data.
  • Importance of research in the respective field.
  • Feature Prospective, Broad area of research, Rigorous methodology, Adequate evidence for its conclusions.
  • The previous literature has been treated fairly and adequately.
  • The research meets all applicable standards for the ethics of experimentation and research integrity.
  • The authors have complied with applicable reporting standards and guidelines for data publication.
  • Avoid presenting your results with raw or unprocessed data.
  • The submission is written clearly and unambiguously in Standard English.

Submission Components

Manuscripts should be submitted by one of the author, who is listed in the manuscript while submitting the manuscript files through EMS, make sure your files are in Word or PDF (.pdf, .doc, .docx, .rtf) format.

Alternatively you can send it to our E-mail address:submission@oatext.com

Submitted manuscripts should typically include the following elements:

  • Cover letter (required)
  • Manuscript (required)
  • Figures
  • Tables
  • Supplemental Material

Authors are encouraged to provide the names and contact information for 3–5 external reviewers, though Associate Editors are not obligated to use these suggestions. Authors may also indicate researchers whom they feel should not review the submission.

For more information, please see our guidelines on Manuscript Preparation.

The Review Process

Each of OA Text journals are led by an Editor-in-Chief and supported by an international Board of Associate Editors, comprised of respected researchers in relevant fields. We are committed to providing Elementa authors with a fair and timely review process, constructive feedback, and a supportive environment. We publish articles that are methodologically sound, that are worthy of inclusion in the scholarly record, and that further research and discourse in the relevant field of study.

Our goal is to make initial decisions on submissions within 21 calendar days. After acceptance, the manuscript and supporting files will be immediately processed for publication, a process taking approximately 10 business days, if all supporting files are in order.

Our review process follows these steps:

  • All manuscripts submitted to OA Text Journals are received by the Editorial Assistant who examines all files including cover letter, text files, images and figures. If the files meet the technical and formatting of OA Text, as given in the Instructions for Authors, authors are sent an acknowledgement of the manuscript along with a Manuscript ID number.
  • After assigning the Manuscript ID number, the manuscript is sent for editorial review and external peer review. Authors are requested to quote the manuscript ID number in all correspondences with OA Text journals. If the manuscript files do not meet the technical requirements of the journal, authors are sent detailed instructions about the changes required in the manuscript and asked to resubmit the files to the Editorial Office, using "Submit Revision" page.
  • After the files pass the technical and formatting requirements, the manuscript is assigned to a Section Editor or a member of the Editorial Board.
  • The Editor reviews the manuscript and returns the manuscripts along with the comments to the Editorial Assistant or Editorial Secretary. The editorial process gives the editors the authority to reject any manuscript, if it doesn’t not meet the scientific publishing standards or is out of scope of the journal.
  • Based on the comments of the Editor the manuscript is sent for the external peer review. The manuscript is usually sent to two to four expert peer reviewers. The peer reviewer's identities are kept confidential to ensure a fair and unbiased review of every manuscript.
  • The pertinent Editor-in-Chief will review submissions to identify those that are appropriate for full review, and assign an Associate Editor to manage the review process.
  • The Associate Editor will select reviewers, manage the review process, and will make one of the following publication recommendations to the Editor-in-Chief:
    • Accept without revision;
    • Invite author(s) to revise the submission to address specific but relatively minor concerns;
    • Invite author(s) to revise the submission to address moderate to major concerns;
    • Reject, but indicate to the author(s) that further work might justify a resubmission; or
    • Reject outright.
  • If a revision is recommended, the Editorial Assistant will include, with her or his review, a short paragraph summarizing the most important issues raised by the reviewers for the author(s) to address and ask the author(s) to include a Response to Reviewers with their revision. In some cases the Editorial Assistant may seek further review from the original or other reviewers.
  • The Editor-in-Chief will make the ultimate decision regarding publication, and communicate directly with the corresponding author on the results of the review process.
  • After acceptance, a Production Editor will perform a technical audit of the final manuscript and supporting files, to ensure that the submission will move through the production process smoothly.
  • After the acceptance of the manuscript, it may be edited for grammar, punctuation, style and accuracy. An edited, pre-print, proof of the manuscript with all figures, table and charts included, is sent to the corresponding author for approval. The proof will be sent as a PDF file. The authors will also be sent a proof corrections form, which the authors can use to submit any changes required in the manuscript. Please note that at this stage only the type-setting like incorrect punctuation will be corrected. It will not be possible to make any significant changes to the text or add or delete figures. The proof need to be returned to the Editorial Office within three days (72 hours).
  • After the correction proofs are received by the Editorial Office, the final version of the manuscript is prepared for publication. During preparation for publication, HTML, PDF, XML and other formats of the manuscript are prepared. After receiving page proofs, the average time to publication is approximately four weeks. All manuscripts are published in HTML and PDF formats.

Hematology & Medical Oncology is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Hematology & Medical Oncology are USD 2160 .

Frequently Asked Questions (FAQs)

Why are your charges set at these levels?

All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

  • Recover capitalization costs;
  • Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
  • Bend the publication-charge cost downward over time.

Who will pay the APC?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

  1. Wire/Bank transfer
  2. Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after  processing of the manuscript.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Withdrawal Charges

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.

Open Access Text is committed to providing high quality articles and uphold the publication ethics to advance the intellectual agenda of science. We expect our authors to comply with, best practice in publication ethics as well as in quality of their articles.

Few of the authors request withdrawal of manuscript from the publication process after submission or after publication. In some instances the request for withdrawal is made when the manuscript is only a few days away from publication in the journal. This may cause the time waste by the editors, reviewers and the editorial staff.

To evade gratuitous withdrawal of manuscripts OA text declared the below withdrawal policy. The corresponding author or co authors should address the below statement before sending a request for withdrawal.

  • All authors include corresponding and co authors should confirm the number of authors, authorship, approval and integrity of the manuscript before submission. In case of any differences of opinion, address the concerns of all the authors before submitting the manuscript for publication.
  • Research students or Researchers should take prior permission from their guides and professors before sending/submitting their manuscripts in OA text journals.
  • Authors should follow the publication ethics (details are included in our Publication ethics page: http://www.oatext.com/PublicationEthics.php)
  • Manuscript is appropriately withdrawn from any previous publisher (if submitted).
  • It is unacceptable to withdraw a manuscript  from a journal because it is being accepted by another journal.
  • Before submitting the manuscript authors should carefully check the facts and data presented in the manuscripts are accurate and error-free.
  • All authors need agree for publishing the articles on the specific journal before submission.

Unethical withdrawal

Advanced stage in the editorial process, when peer reviews were near completion was unacceptable unless there are compelling reasons.

If the author withdraws a manuscript after publication, the article publication charges, if paid by the authors, will not be refunded.

If the authors do not reply to communication from the editorial office, even after multiple reminders, at any stage of the publication process; OA text Journals holds all rights to disclose the conduct of the authors and content of the manuscript without further approval from the authors, and cannot be held responsible for the consequences arising from it.

Withdrawal of a manuscript will be permitted only for the most compelling and unavoidable reasons. For withdrawal of a manuscript authors need to submit an "Article withdrawal Form", signed by all authors mentioning the reason for withdrawal to the Editorial Office. The form is available from the editorial office of the journal. Authors must not assume that their manuscript has been withdrawn until they have received appropriate notification to this effect from the editorial office.

In a case where a manuscript has taken more than six months time for review process, that allows the author to withdraw manuscript without paying any charges.

Manuscript withdrawal charges

The author is allowed to withdraw the manuscript without paying any withdrawal penalty, if the author(s) requests a withdrawal of manuscript, within 48 hours of submission.

If the author(s) requests a withdrawal of manuscript, after the peer review process or in the production stage (Early Release or Ahead of publishing) or published online; then authors need to make a withdrawal penalty.

OA text Journal Editorial Office will provide the corresponding author a formal letter of Manuscript Withdrawal. Withdrawal of manuscripts is only allowed after withdrawal penalty has been fully paid to the OA text Editorial Office.

As per the policy, we declare that the withdrawal charges are applicable in case of withdrawal.

Withdrawal form

If the author wish to withdraw paper from a journal, author needs to submit an " Article withdrawal Form" signed by all authors (or) the corresponding author of the manuscript stating the reasons for manuscript withdrawal. The form is available from the Editorial Office of the journal.

Submission Instructions

General Instructions for Figures

  • Include relevant clinical, radiological and pathological images with the manuscript to give it a visual accept and increase the impact of your work on the readers.
  • The following file formats are accepted for figures submitted to OA Text: JPEG, PNG, TIFF, BMP, GIF, and Power Point
  • Make all effort to preserve the anonymity of the patients. if photographs of an individual is used in which a person can be identified, written informed consent must be obtained and submitted to the Editorial Office. This permission is separate from the permission taken from the patient to publish the case.
  • If you include text or figures that have been published elsewhere, you must obtain permission is separate from the permission taken from the patient to publish the case.
  • If you include text or figures that have been published elsewhere, you must obtain permission from the copyright owner(s). All expenses for obtaining such permission will have to be paid by the authors(s). If you are unable to pay for obtaining permission to use previously published work, we suggest that you use other work available free to refer and cite in your manuscript.
  • Figures should be numbered consecutively according to the order in which they have been first cited in the text.
  • Mention the figure numbers in the text at the appropriate places in parenthesis before the punctuation marks. e.g. (Figure 1) or (Figure 1A, 2) or (Figure 1A, 1C, 3-5) or (Figures 1-3) or (Figures 1,4-6)
  • Do not include images in the main manuscript text file.
  • All figures should be provided as separate files.
  • Includecolor figures wherever possible.
  • The file name should include the figure number. Label file names as:Figure1, Figure2 etc. If multiple figures form a part of a sequence label them as Figure 1(A), Figure 1(B) etc.
  • Figure files should have a minimum of 300 pixels per inch (ppi) if in color or halftone, or at 1200 ppi if as line art. Digital scanned line drawings should have a minimum resolution of 800 dpi. Figures containing color should be in RGB (millions of colors), 8 bits per channel. No other color space is allowed, such as CMYK, indexed, or bitmap. Save grayscale or RGB files with a depth of 8 bits per channel, not 16.
  • Try to keep all images separate. You do not need to combine multiple images into a single image.
  • If it is necessary to combine multiple figures into one composite figure, figure parts should be denoted on the figure by uppercase letters (A, B, C etc.). Label each figure in the lower left hand corner (for Figure 1(A), label figure as 'A', for Figure 1(B), label figure as 'B',without quotes). Labels should not include the word'Figure'. The size of the letters should be large enough to be easily visible. Use font color so that letters contrast with the background. Keep letters of a consistent size in all the figures. You can use symbols, arrows or letters in the figures to indicate important areas or parts. Do not put the title of figures or explanations on the figure. Mention them in the figure legends.
  • If a figure has been published elsewhere, you will have to submit written permission from the copyright holder to reproduce the materials at the time of submitting the Author Agreement Form.
  • Please provide figure legends on a separate page with Arabic numerals corresponding to the figures.
  • The legend should be included in the manuscript text file immediately following the references.
  • Give a good description of the figure. When arrows, symbols or letter are used to identify parts of figure, identify and explain each one in the legend. Give the magnification and identify the method of staining in photomicrographs.
  • Figure legend should begin with term 'Figure' followed by figure number (e.g. 'Figure 1').
  • Do not use any abbreviations unless their full forms are given (excluding common abbreviations such as names of antibodies.)
  • Text within a figure should be Arial, Times, and/or Symbol 6-12 point to ensure legibility. EPS text in other fonts may be lost or render improperly, so should be converted to outlines. Do not include author names, article title, or figure number/title/caption within figure files.
  • Create figures with a white background. Figures with a transparent background may not display well online.
  • Figures should be cropped to minimize surrounding white space. A 2-point white space border around each figure is recommended to prevent inadvertent cropping of content at layout.
  • TIFF files with multiple layers are not acceptable. Figures with a single layer named “layer 1” or “layer 0” are in fact “layered.” Please provide a flattened version of any multiply layered file.
  • If you use excel to generate your graph, avoid 3D, crowded axes, colored background, strong grid etc.. Use Tahoma font (size 10 maximum) for all items in your graphs (Title, legend, axes etc..). Expand your Excel graph to obtain a large image, copy and paste it in Paint (Microsoft Paint), crop any white border and save the image as PNG or JPEG. Submit this image for your manuscript
  • If you plan on submitting a stereogram as one of your figures, make sure this is clearly mentioned in the caption for the figure within the manuscript. Stereograms must be sized so that the centers of each of these images are 63 mm apart. Make sure that the stereogram figure is at the size you would like them to display.
  • The journal reserves the right to modify, crop, rotate, reduce, or enlarge the photographs to an acceptable size.

Table Preparation

  • The table numbers should be cited at the relevant places in the text in parenthesis after the punctuation mark .e.g. (Table 1) or (Tables 1-4) or (Tables 1,3,6-8).
  • We impose no limit on the number of tables submitted, but we do require that all tables—main or supplemental—be well described. Good metadata are key to discoverability and usefulness.
  • Each table should be numbered in the order of first citation in the text, using Arabic numerals, e.g. Table 1.
  • You will need to send your original, editable files (e.g. in Microsoft Word or Excel). This will reduce the likelihood of errors being introduced during production of your article.
  • Non-editable files (e.g. JPEG or TIFF images, or images of text boxes in PowerPoint) are not suitable formats but can be included in addition to the editable files for reference.
  • Each table should appear on separate page.
  • A title for every table which summarizes the whole table must be given above the table.
  • Please present table titles separately for each table, rather than including them as the first row of the table. Table notes should be separate from the titles and included underneath the table to which they apply.
  • Tables should present new information rather than duplicating what is in the text. Readers should be able to interpret the table without reference to the text.
  • Tables should be self-explanatory and not duplicate the data presented in figures.
  • Tables do not have strict dimension requirements. However, some wide tables may be printed sideways in the PDF version of the article. Very large tables may span more than one page in the PDF.
  • When submitting multiple tables, consistency in presentation is advised where possible.
  • Kindly prepare tables using the table function of word processing program like Microsoft Word. Do not use spaces or table for making tables.
  • Charts should be sent as Excel or PowerPoint files.
  • Place explanations, comments and full form of non-standard abbreviations in footnotes below each table.
  • If some materials have been taken from previously published literature, give the reference at the end of table caption, and include the citation in the list of references at appropriate places.
  • Please note that color, shading, vertical rules, and other cell borders are not compatible with our publishing requirements. Where necessary please use notes, italics, or bold text for emphasis with accompanying footnotes explaining their significance.
  • Where superscript notes are used, the letters should follow alphabetical order from the top left of the table to the bottom right. All statistical significance notes should be represented in the table, or deleted. Please also add notes explaining any acronyms or abbreviations in table titles or column headings.
  • When representing information numerically, use as many decimal places as is appropriate for your purposes. This number should be consistent throughout the column, or table if possible.
  • The text in your table will be copy-edited to match the style of the journal.
  • Refer to each table in the text.
  • If you are sending tables in a separate file, insert a note in the text indicating the preferred location for each table, e.g. [t]Table 1 near here[/t].
  • Supplemental tables referenced within the text, but not integrated into the PDF version of the article. Supplemental material provides readers with additional information that enhances the main text but is not critical to its assertions. (For detailed information, please see Supplemental Material & Data.)

Requirements

Tables must

  • -be cell-based (e.g., created in Word with Tables tool (preferred), Rich Text, or LaTex;
  • -be editable (i.e., not a graphic object);
  • -be organized with rows and columns, not with returns, spaces, or tabs;
  • -have heading/subheading levels in separate columns;
  • -multi-part tables with varying numbers of columns or multiple footnote sections should be divided and renumbered as separate tables.

Tables must not:

  • -use returns or tabs within a cell;
  • -have color or shading;
  • -use lines, rules, or borders;
  • -contain spaces within cells to align text;
  • -have vertically merged cells (horizontally merged cells are fine);
  • -have inserted text boxes or pictures;
  • -contain tables within tables or cells within cells;
  • -include empty columns, rows, or cells to create spacing;
  • -include hyperlinked text.
  • If your submitted table contains any of these elements, they will be returned for adjustments.

Supplemental Material Submission Instructions

Deposit of Primary Data

Supplemental Material Submission Instructions

What to Submit as Supplemental Material

Supporting material that cannot be included, and which is not essential for inclusion, in the full text of the manuscript, but would nevertheless benefit the reader. It should not be essential to understanding the conclusions of the paper, but should contain data that are additional or complementary and directly relevant to the article content. Authors are encouraged to take advantage of the opportunity to submit Supplementary data whenever appropriate; for example, when the amount of material is too great to warrant inclusion in the main body of the paper, or when the material is in a format that cannot be represented in print (i.e. video clips or animated graphics). Please note that atomic co-ordinates used to create molecular models described in a manuscript, unless deposited in a publicly available database, must be made available as Supplementary data.

All material to be considered as Supplementary data must be submitted at the same time as the main manuscript for peer review. Please indicate clearly the material intended as Supplementary data upon submission. Also ensure that the Supplementary data is referred to in the main manuscript at an appropriate point in the text. It cannot be altered or replaced after the paper has been accepted for publication. [Supporting material that has not been peer reviewed will not be published as Supplementary data (so will not be designated 'S' in the Table of Contents), but can be made available through a link to the author's home page, at the discretion of the Executive Editor handling the paper. The word 'Supplementary' must not be used to describe this material. Please use words such as 'Supporting material' or 'Additional material'.

Supplementary data should be submitted in a separate file(s), in its final form. Please note that Supplementary data will not be edited, so ensure that it is clearly and succinctly presented, and that the style of terms conforms to the rest of the paper. Also ensure that the presentation will work on any internet browser.

Note: Supplementary data is considered as published material and is regulated by the same copyright and permissions rules as the published article to which it belongs.

Metadata

Although we do not limit the number or type of Supplemental Material items authors may include, we do require that they provide a relevant and useful expansion of the article, and that they be as well described as are figures and tables included within the body of the article. Good metadata of this material are key to discoverability and usefulness. All Supplemental Material should include the following:

  • Type and number: Supplemental material can be named in almost any way, provided that the files are consistently named, and numbers are preceded by “S” and closed with a period. Examples:
    • Figure S1.
    • Table S1.
    • Text S1.
    • Video S1.
    • Animation S1.
    • Alternative Language Abstract S1.
  • Figures, Tables, Videos, Animations should be provided with titles should be no more than 15 words and set in bold type, using sentence case.
  • Supplemental material figures and tables should follow the requirements for main-text figures and tables (seeFigure Preparationand Table Preparation).
  • Other types of supplementary material files should include a caption of no more than 300 words should, describing the key message of the figure/video/animation in such a way that readers can interpret the file without referring to the text.
  • Citation In-Text

    All Supplementary data MUST be referred to in the main manuscript at an appropriate point in the text, just as main text figures and tables. This offers readers context and allows for seamless interlinking. Text citations should use the appropriate type and number designation (e.g., Video S1). Supplementary data should be made available by the publisher as online-only content, linked to the online manuscript. Such data should consist of electronic files and should not merely be a link to another web site.

    Acceptable formats

    The supplementary data should preferably be saved as one single PDF file, including all text, figures, tables and legends. If this is not possible, a maximum of 10 files is acceptable to make up the supplementary data unit for the article.We prefer that Supplemental Material files not exceed 10MB. However, if that size limit results in a loss of quality (e.g., by making the dimensions smaller or compressing a movie in such a way as to compromise image quality), we can accept larger files.

    Text files

    Supplementary text should be submitted as text files in MS Word (.doc), HTML (.php) or RTF (.rtf) format.And should be mentioned appropriately in text.

    Spreadsheet files in MS Excel (.xls) or CSV format. Where possible, combine all tables into a single Excel workbook, saving individual tables on separate clearly labelled worksheets (tabs).

    Figures

    Supplemental figures should be submitted as separate tif, gif or jpg files at a minimum resolution of 300 ppi, just as with main figures (please see ourFigure Preparationsection for detailed instructions on figure preparation).

    Videos & audio clips

    For videos, please try to submit videos &audio clips of reasonable quality. We highly recommend videos to be submitted in MP4 formatand audio clips in mp3 format.Whatever format you use, videos must open and play in either QuickTime Player v. 7.6.2 or Windows Media Player v. 11.

    Authors who have video and/or audio clips that they wish to submit their article are strongly encouraged to include these within the body of the article. This can be done in the same way as a figure or table by referring to the multimedia content and noting in the body text where it should be placed with its associated caption.

    Help

    If you require further help or information regarding submission or preparation of Supplementary data, pleaseinfo@oatext.com

Deposit of Primary Data

An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. Therefore, a condition of publication in a OA Text journal is that authors are required to make materials, data and associated protocols promptly available to readers without undue qualifications. Any restrictions on the availability of materials or information must be disclosed to the editors at the time of submission. Any restrictions must also be disclosed in the submitted manuscript, including details of how readers can obtain materials and information. If materials are to be distributed by a for-profit company, this must be stated in the paper.

Data sets will be made freely available to readers from the date of publication, and must be provided to editors and peer-reviewers at submission, for the purposes of evaluating the manuscript.

For the following types of data set, submission to a community-endorsed, public repository is mandatory. Accession numbers must be provided in the paper. Examples of appropriate public repositories are listed below.

Deposition of sequence and structural data

Sequence information, co-ordinates used to create molecular models described in a manuscript, and structural data must be submitted in electronic form, prior to acceptance, to the appropriate database for release no later than the date of publication of the corresponding article in the Journal. Deposition numbers and/or accession numbers provided by the database should be included in the manuscript and entered into the relevant boxes during online submission or communicated to the Executive Editor handling the manuscript as soon as received. In cases where there may be no appropriate database, authors must make their data available on request. Atomic co-ordinates may be included in the publication as supplementary material. Manuscripts will not be published until the Journal is in receipt of the deposition number.

For papers reporting novel nucleic acid sequences

Nucleic acid sequence information must be deposited with one of the three major collaborative databases (EMBL/GenBank/DDBJ). For sequences obtained from a public or private web site, it is the author's responsibility to ensure that any sequence used within the manuscript is deposited before publication. It is necessary to submit sequences to one database only since data are exchanged between EMBL, GenBank and DDBJ on a daily basis. New sequence names and their accession numbers should be listed at the beginning of the Materials and Methods section to aid searches by readers. In order to allow new methods of data search,NAR encourages authors to cite GenBank accession numbers when referring to established sequences within their manuscript.

For Illumina-type sequencing, authors are encouraged to submit raw Illumina data to the NCBI’s Sequence Read Archive, and to include corresponding accession numbers in the manuscript.

For papers reporting novel Macromolecular structures

Authors of papers describing structures of biological macromolecules must provide atomic coordinates and related experimental data (structure factor amplitudes/intensities for crystal structures, or restraints for NMR structures) upon request of editors for the purposes of evaluating the manuscript, if they are not already freely accessible in a publicly available and recognized database (for example,Protein DataBank,Uniprot,Nucleic Acids DatabaseorBiological Magnetic Resonance Databank). Electron microscopy-derived density maps and coordinate data must be deposited inEMDB.

Crystallographic data for small molecules

Manuscripts reporting new three-dimensional structures of small molecules from crystallographic analysis should include a .cif file and a structural figure with probability ellipsoids for publication as Supplementary Information. The structure factors for each structure should also be submitted. Both the strucure factors and the structural output must have been checked using the IUCR's CheckCIF routine, and a PDF copy of the output must be included at submission, together with a justification for any alerts reported. Crystallographic data for small molecules should be submitted to the Cambridge Structural Database and the deposition number referenced appropriately in the manuscript. Full access must be provided on publication.

Databases: The Cambridge Crystallographic Data Centre (CCDC) is appropriate for deposition of data on nucleosides, nucleotides and other small molecules.

A member site of theWorldwide Protein Data Bank:RCSB PDB, Protein Databank in Europe (PDBe),Protein Databank in Japan (PDBj), orBMRBis appropriate for deposition of data on proteins determined by X-ray crystallography and for all macromolecules determined by NMR methods.

The Nucleic Acid Database (NDB) is appropriate for atomic co-ordinate and structure factor data for crystal structures of nucleic acids. This can generally be handled by the Worldwide Protein Data Bank or RCSB Protein Data Bank described above.

NMR papers: Resonance assignments should be reported relative to DSS and not to HOD.

For papers reporting novel protein sequences

Protein sequences, which have been determined by direct sequencing of the protein, must be submitted toUniProt(i.e. TrEMBL, Swiss-Prot and PIR) using the interactive submission tool SPIN. Please note that they do not provide accession numbers, IN ADVANCE, for protein sequences that are the result of translation of nucleic acid sequences. These translations will forwarded automatically from the nucleotide sequence databases (EMBL/GebBank/DDBJ) and assigned UniProt accession numbers on incorporation into UniProt. Results from characterization experiments should also be submitted toUniProt: for novel sequences, these should be included with the sequence submission. Existing UniProt entries should also be updated. This can include information such as function, subcellular location, subunit, etc.

For papers reporting new ChIP-Seq data

New ChIP-Seq data must be deposited in GEO, with accession numbers at or before acceptance for publication.

Microarray data

All authors must comply with the'Minimal Information About a Microarray Experiment' (MIAME)guidelines published by the Microarray Gene Expression Data Society. NAR also requires submission of microarray data to the GEO or ArrayExpress databases, with accession numbers at or before acceptance for publication.

Quantitative PCR

Authors are encouraged to follow the'Minimal Information for Publication of Quantitative Real-Time PCR Experiments' (MIQE)guidelines, if appropriate. The guidelines are published by the Real-Time PCR Data Markup Language Consortium and can be found athttp://www.rdml.org/miqe.php

Other datasets

In addition to the above-mentioned mandatory requirements for data submission to community-endorsed public databases, Nature journals strongly recommend deposition of other types of data sets into appropriate public repositories that are at an earlier stage of development. Examples of such repositories that facilitate sharing large data sets, some of which can offer the option of anonymous referee access to data before publication, include:

Manuscript Preparation

The manuscript preparation guidelines are adapted from those developed forInternational Committee of Medical Journal Editors. Careful attention to these guidelines will help ensure that your manuscript will move through the peer-review process smoothly and quickly.

Submissions to OA Text consist of the following components:

Reference Style Guide

We use Scientific Style and Format: The CSE Manual for Authors, Editors, and Publishers (7th Edition, 2006) as our primary style guide and highly recommend that authors consult it.

The purpose of a reference list is to enable sources to be easily traced by another reader. Different types of publication require different amounts of information but there are certain common elements such as authorship, year of publication and title.

Any reference that is cited only in the tables or figures legends should be numbered according to the first identification of the table or figure in the main text in continuation with the sequence of citation numbering.

Place the reference immediately after the author name or if author name is not included in the sentence, at the end of the sentence after the punctuation mark.

Each reference must have a reference number. Reference should not be used in titles, headings or abstract. Use complete names for non-indexed journals

Avoid citing unpublished data or manuscripts, personal communications, websites, conference papers and non-peer reviewed publications. Avoid citing very old references.

The following guidelines, based on the CSE Manual, are intended to assist you in formatting references accurately and consistently.

Basic Reference Formatting

The reference list (appearing at the end of the article) should be numbered in the order that they appear in the text.

All references in text, tables, and legends must be identified by consecutive Arabic numerals in square brackets, listed immediately before the closing punctuation mark. E.g. [1] or [1,2] or [1-4] or [1-4,6] or [1,2,5-9] or [1,4-7,9, 11-20].

Published works, works accepted for publication, and citable datasets should appear in the reference list. Mentions of unpublished work should be cited parenthetically within the main text of the article as personal communications.

Citing References In-Text

Any in-text reference should include the authorship and the year of the work. Depending on the nature of the sentence/paragraph that is being written, references to sources may be cited in the text as described below:

Author's name cited in the text

When making reference to an author's work in your text, their name is followed by the year of publication of their work:

In general, when writing for a professional publication, it is good practice to make reference to other relevant published work. This view has been supported in the work of Cormack (1994).

Where you are mentioning a particular part of the work, and making direct reference to this, a page reference should be included:

Cormack (1994, pp.32-33) states that "when writing for a professional readership, writers invariably make reference to already published works".

Author's name not cited directly in the text

If you make reference to a work or piece of research without mentioning the author in the text then both the author's name and publication year are placed at the relevant point in the sentence or at the end of the sentence in brackets:

Making reference to published work appears to be characteristic of writing for a professional audience (Cormack, 1994).

More than one author cited in text

Where reference is made to more than one author in a sentence, and they are referred to directly, they are both cited:

Smith (1946) and Jones (1948) have both shown ...

Two or three authors for a work

When there are two or three authors for a work, they should be noted in the text

Directly using an and

White and Brown (2004) in their recent research paper found...

Or indirectly

Recent research (White and Brown, 2004) suggests that...

Other examples using two or three authors........

During the mid nineties research undertaken in Luton (Slater and Jones, 1996) showed that...

Further research (Green, Harris and Dunne, 1969) showed

When there are two or three authors for a work they should all be listed (in the order in which their names appear in the original publication), with the name listed last preceded by an and.

Four or more authors for a work

Where there are several authors (four or more), only the first author should be used, followed by et al. meaning and others:

Green, et al. (1995) found that the majority ...

or indirectly:

Recent research (Green, et al., 1995) has found that the majority of ...

More than one author not cited directly in the text

List these at the relevant point in the sentence or at the end of the sentence, putting the author’s name, followed by the date of publication and separated by a semi-colon and within brackets.

Where several publications from a number of authors are referred to, then the references should be cited in chronological order (i.e. earliest first):

Further research in the late forties (Smith, 1946; Jones, 1948) led to major developments......

Recent research (Collins, 1998; Brown, 2001; Davies, 2008) shows that

Several works by one author in different years

If more than one publication from an author illustrates the same point and the works are published in different years, then the references should be cited in chronological order (i.e. earliest first):

as suggested by Patel (1992; 1994) who found that...

or indirectly:

research in the nineties (Patel, 1992; 1994) found that...

Several works by one author in the same year

If you are quoting several works published by the same author in the same year, they should be differentiated by adding a lower case letter directly, with no space, after the year for each item:

Earlier research by Dunn (1993a) found that...but later research suggested again by Dunn (1993b) that ...

If several works published in the same year are referred to on a single occasion, or an author has made the same point in several publications, they can all be referred to by using lower case letters (as above):

Bloggs (1993a; 1993b) has stated on more than one occasion that ...

Chapter authors in edited works

References to the work of an author that appears as a chapter, or part of a larger work, that is edited by someone else, should be cited within your text using the name of the contributory author not the editor of the whole work.

In his work on health information, Smith (1975) states ...

In the reference list at the end of your document, you should include details of both the chapter author and the editor of the entire work

Smith, J., 1975. A source of information. In: W. Jones, ed. 2000. One hundred and one ways to find information about health. Oxford: Oxford University Press. Ch.2

Corporate authors

If the work is by a recognised organisation and has no personal author then it is usually cited under the body that commissioned the work. This applies to publications by associations, companies, government departments etc. such as Department of the Environment or Royal College of Nursing.

It is acceptable to use standard abbreviations for these bodies, e.g. RCN, in your text, providing that the full name is given at the first citing with the abbreviation in brackets:

1st citation:

... following major pioneering research in 2006 undertaken by the Royal College of Nursing (RCN) it has been shown that ...

2nd citation:

More recently the RCN (2007) has issued guidelines for...

Note that the full name is the preferred format in the reference list. These should provide the full name...

Royal College of Nursing, 2006.Children in the Community. London: RCN.

Royal College of Nursing, 2007.Administering intravenous therapy to children in the community setting: Guidance for nursing staff. London: RCN.

Some reports are written by specially convened groups or committees and can be cited by the name of the committee:

Committee on Nursing (1972)

Select Committee on Stem Cell Research (2002)

Note there are some exceptions to this such as:

BBC Philharmonic Orchestra

BBC News

where the abbreviations or initials form part of the official name.

No author

If the author cannot be identified use 'Anonymous' or 'Anon' and the title of the work and date of publication. The title should be written in italics.

Marketing strategy (Anon., 1999)

No date

The abbreviation n.d. is used to denote this:

Smith (n.d.) has written and demonstrated......

or indirectly:

Earlier research (Smith, n.d.) demonstrated that......

Every effort should be made to establish the year of publication if you intend to use this work as supporting evidence in an academic submission.

Page Numbers

Including the page numbers of a reference will help readers trace your sources. This is particularly important for quotations and for paraphrasing specific paragraphs in the texts:

Lawrence (1966, p.124) states "we should expect ..."

or indirectly:

This is to be expected (Lawrence, 1966, p.124)...

Please note page numbers: preceded with p. for a single page and pp. for a range of pages.

Quoting portions of published text

If you want to include text from a published work in your essay then the sentence(s) must be included within quotation marks, and may be introduced by such phrases as:

the author states that "............"

or

the author writes that "............"

On the topic of professional writing and referencing Cormack and Brown (1994, p.32) have stated...

"When writing for a professional readership, writers invariably make reference to already published works..."

In order for a reader to trace the quoted section it is good practice to give the number of the page where the quotation was found. The quotation should also be emphasized (where it is 50 words or more) by indenting it and enclosed in quotation marks. This clearly identifies the quotation as the work of someone else:

"Outside the UK, the BBC World Service has provided services by direct broadcasting and re-transmission contracts by sound radio since the inauguration of the BBC Empire Service in December 1932, and more recently by television and online. Though sharing some of the facilities of the domestic services, particularly for news and current affairs output, the World Service has a separate Managing Director, and its operating costs have historically been funded mainly by direct grants from the UK government. These grants were determined independently of the domestic licence fee. A recent spending review has announced plans for the funding for the world service to be drawn from the domestic licence fee". (Jones, 1967, p.27)

Secondary sources (second-hand references)

You may come across a summary of another author's work in the source you are reading, which you would like to make reference to in your own document; this is called secondary referencing.

A direct reference:

Research recently carried out in the Greater Manchester area by Brown (1966 cited in Bassett, 1986, p.142) found that ...

In this example, Brown is the work which you wish to refer to, but have not read directly for yourself. Bassett is the secondary source, where you found the summary of Brown's work.

Or indirectly:

(Brown, 1966 cited in Bassett, 1986, p.142)

It is important to realise that Bassett may have taken Brown's ideas forward, and altered their original meaning. If you need to cite a secondary reference it is recommended that, where possible, you read the original source for yourself rather than rely on someone else's interpretation of a work. For this reason it is best to avoid using secondary referencing.

The reference list at the end of your document should only contain works that you have read.

Tables and diagrams

When reproducing selected data, or copying an entire table or diagram, a reference must be made to the source. A reference within the text to a table taken from someone else's work, should include the author, date and page (Smith, 2005, p.33) to enable the reader to identify the data. If the source of the data is not the author's own, but obtained from another source, it becomes a secondary reference and needs to be cited as such:

(United Nations, 1975 cited in Smith, 2005, p.33)

If the table is reproduced in its entirety, place the citation below the table. Be particularly careful to note the original source of data, as well as the authorship of the document you are using. Full details should be included in the reference list.

Websites

When citing material found on a website, you should identify the authorship of the website. This may be a corporate author, an organisation or a company; a guide to this can be found by looking at the URL or web address. To find the date of publication, reference to this might be found at the bottom of a web page relating to copyright, or from a date headline.

Using Books, Journals and Newspapers

General Format

Author(s).Date.Title of the book.Edition. Place of publication: Publisher: Extent. (Series).Notes.

Books with one author

Use the title page, not the book cover, for the reference details. Only include the edition where it is not the first. A book with no edition statement is most commonly a first edition.

The required elements for a book reference are:

Author, Initials., Year. Title of book.Edition. (only include this if not the first edition) Place of publication (this must be a town or city, not a country): Publisher.

Reference

where 1st edition

Baron, D. P., 2008.Business and the organisation. Chester: Pearson.

where 3rd edition

Redman, P., 2006. Good essay writing: a social sciences guide. 3rd ed. London: Open University in assoc. with Sage.

An intext reference for the above examples would read:

Organisations have been found to differ (Baron, 2008) when there is ...

Leading social scientists such as Redman (2006) have noted ...

Please note where there is likely to be confusion with UK place names; for USA towns include the State in abbreviated form e.g. Birmingham, AL.

Books with multiple authors

For books with multiple authors, all the names should all be included in the order they appear in the document. Use an and to link the last two multiple authors.

The required elements for a reference are:

Authors, Initials., Year. Title of book.Edition. (only include this if not the first edition) Place: Publisher.

Reference

Adams, R. J.,Weiss, T.D. and Coatie, J.J., 2010. The World Health Organisation, its history and impact. London: Perseus.

Barker, R., Kirk, J. and Munday, R.J., 1988.Narrative analysis. 3rd ed. Bloomington: Indiana University Press.

An intext reference for the above examples would read:

Leading organisations concerned with health (Adams, Weiss and Coatie, 2010) have proved that...

A new theory (Barker, Kirk and Munday, 1988) has challenged traditional thinking...

Books which are edited

For books which are edited give the editor(s) surname(s) and initials, followed by ed. or eds..

The required elements for a reference are:

Author, Initials., ed., Year. Title of book.Edition. Place: Publisher.

Keene, E. ed., 1988.Natural language. Cambridge: University of Cambridge Press.

Silverman, D.F. and Propp, K.K. eds., 1990.The active interview. Beverly Hills, CA: Sage.

Allouche, Jose. ed., 2006. Corporate social resposibility, Volume 1: concepts, accountability and reporting. Basingstoke: Palgrave Macmillan.

Chapters of edited books

For chapters of edited books the required elements for a reference are:

Chapter author(s) surname(s) and initials., Year of chapter. Title of chapter followed by In: Book editor(s) initials first followed by surnames with ed. or eds. after the last name. Year of book.Title of book. Place of publication: Publisher. Chapter number or first and last page numbers followed by full-stop.

References

Samson, C., 1970. Problems of information studies in history. In: S. Stone, ed. 1980. Humanities information research. Sheffield: CRUS. pp.44-68.

Smith, J., 1975. A source of information. In: W. Jones, ed. 2000. One hundred and one ways to find information about health. Oxford: Oxford University Press. Ch.2.

An intext reference for the above example would read:

(Samson, 1970)

(Smith, 1975)

Multiple works by the same author

Where there are several works by one author and published in the same year they should be differentiated by adding a lower case letter after the date.

Remember that this must also be consistent with the citations in the text

For multiple works the required elements for a reference are:

Author, Initals., Year followed by letter. Title of book. Place: Publisher.

Soros, G., 1966a. The road to serfdom. Chicago: University of Chicago Press.

Soros, G., 1966b. Beyond the road to serfdom. Chicago: University of Chicago Press.

Works by the same author should be displayed in the order referenced in your assignment, earliest first (as above).

An intext reference for the above example would read:

(Soros, 1966a)

(Soros, 1966b)

This also applies if there are several authors with the same surname. As an alternative their initials can be included in the citation.

So for example, if you have sources written by George Soros and also by Manuel Soros, you would list them in alphabetic order:

(Soros, G. 1966a)

(Soros, G. 1966b)

(Soros, M. 1966)

Books- translations/imprints/reprints

For works which have been translated the reference should include details of the translator, the suggested elements for such references being:

Author, Initials., Year. Title of book. Translated from (language) by (name of translator, initials first, then surname) Place of publication: Publisher.

Canetti, E., 2001. The voices of Marrakesh: a record of a visit. Translated from German by J.A.Underwood. San Francisco: Arion.

For major works of historic significance, the date of the original work may be included along with the date of the translation:

Kant, I., 1785. Fundamental principles of the metaphysic of morals.Translated by T.K. Abbott., 1988. New York: Prometheus Books.

For works in an another language, reference these in the same manner as an English language work but provide a translation. Students should check with their Faculty the validity of including original language works.

E-books and pdfs

E-books available through the University Library

For e-books accessed through a password protected database from the University Library the required elements for a reference are:

Author, Initials., Year, Title of book. [e-book] Place of publication: Publisher. Followed by Available through: Anglia Ruskin University Library websitehttp://libweb.anglia.ac.uk[Accessed date].

Fishman, R., 2005. The rise and fall of suburbia. [e-book] Chester: Castle Press. Available through: Anglia Ruskin University Library websitehttp://libweb.anglia.ac.uk[Accessed 12 May 2010].

Carlsen, J. and Charters, S., eds. 2007. Global wine tourism. [e-book] Wallingford: CABI Pub. Available through: Anglia Ruskin University Library websitehttp://libweb.anglia.ac.uk[Accessed 9 June 2008].

For an open access e-book freely available over the internet such as through Google books

The required elements for a reference are:

Author, Initials., Year. Title of book. [e-book] Place of publication (if known): Publisher. Followed by Available at: e-book source and web address or URL for the e-book [Accessed date].

Cookson, J. and Church, S. eds., 2007.Leisure and the tourist. [e-book] Wallingford: ABS Publishers. Available at: Google Bookshttp://booksgoogle.com[Accessed 9 June 2008].

For an e-book from specific e-readers and other devices such as Kindle, or Nook

The required elements for a reference are:

Author, Initials., Year, Title of book. [e-book type] Place of publication (if available): Publisher. Followed by Available at: e-book source and web address [Accessed date].

Patterson, M. 2012. Lost places in dreams. [Kindle DX version] Transworld Media. Available at: Amazon.co.ukhttp:// www.amazon.co.uk[Accessed 9 June 2012].

If you include a quotation from an ebook without page numbers, use the section heading or chapter heading as a guide to locating your quotation, if available.

PDF documents

For a pdf version of, for example, a Government publication or similar which is freely available:

The required elements for a reference are:

Authorship, Year.Title of documents. [type of medium] Place of publication (if known): Publisher. Followed by Available at: include web address or URL for the actual pdf, where available [Accessed date]. Bank of England, 2008.Inflation Report. [pdf] Bank of England. Available at: [Accessed 20 April 2009].

Department of Health, 2008. Health inequalities: progress and next steps. [pdf] London: Department of Health. Available at:http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_085307[Accessed 9 June 2008].

Print journal articles

For journal articles the required elements for a reference are:

Author, Initials., Year. Title of article. Full Title of Journal, Volume number (Issue/Part number), Page number(s).

Boughton, J.M., 2002. The Bretton Woods proposal: an brief look. Political Science Quarterly, 42(6), p.564.

Cox, C., 2002. What health care assistants know about clean hands. Nursing today, Spring Issue, pp.647-85.

Perry, C., 2001. What health care assistants know about clean hands. Nursing Times, 97(22), pp.63-64.

General Format

Author(s).Date.Article title. Journal Title volume(issue): pages. doi.

Fewer than Five Authors

Steffen W, Crutzen PJ, McNeill, JR. 2007. The Anthropocene: Are Humans Now Overwhelming the Great Forces of Nature. Ambio 36(8): 614-621.

doi: http://dx.doi.org/10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2

More than Five Authors

Doxa A , Robert A , Crivelli A, Catsadorakis G, Naziridis T, et al. 2012. Shifts in breeding phenology as a response to population size and climatic change: A comparison between short- and long-distance migrant species. Auk 129(4): 753-762. doi: http://dx.doi.org/10.1525/auk.2012.11213

Journal articles accessed through a database

For journal articles from an electronic source accessed through a password protected database from the University Library the required elements for a reference are:

Author, Initials., Year. Title of article. Full Title of Journal, [type of medium] Volume number (Issue/Part number), Page numbers if availalble. Available through: Anglia Ruskin University Library website [Accessed date]

Boughton, J.M., 2002. The Bretton Woods proposal: an in depth look. Political Science Quarterly, [e-journal] 42(6). Available through: Anglia Ruskin University Library website http://libweb.anglia.ac.uk[Accessed 12 June 2005].

An example of a Cochrane Review

Katchamart, W., Trudeau, J., Phumethum, V. and Bombardier, C., 2010.Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis. Cochrane Database of Systematic Reviews, [online] 4 (CD008495) Available at:http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008495/abstract[Accessed 6 August 2013].

An example of an early view article from the BMJ

Currie, G.P., Small, I. and Douglas, G., 2013.Long acting Β2 agonists in adult asthma. BMJ [e-journal] Early view article: Accepted 20 May 2013, Published 6 August 2013, BMJ2013 ;347:f4662. Available at:http://www.bmj.com/content/347/bmj.f4662[Accessed 8 August 2013].

Journal abstract from a database

For a journal abstract from a database where you have been unable to access the full article, the required elements for a reference are:

Author, Initials., Year. Title of article. Full Title of Journal, [type of medium] Volume number (Issue/Part number), Page numbers if availalble. Abstract only.

Available through: Source [Accessed date].

Boughton, J.M., 2002. The Bretton Woods proposal: a brief look. Political Science Quarterly, [e-journal] 42(6). Abstract only. Available through: Anglia Ruskin University Library websitehttp://libweb.anglia.ac.uk[Accessed 12 June 2005].

Every effort should be made to read the article in full if you intend to use this work as supporting evidence in an academic submission.

News paper articles

For newspaper articles the required elements for a reference are:

Author, Initials., Year. Title of article or column header.Full Title of Newspaper, Day and month before page numbers and column line.

Slapper, G., 2005. Corporate manslaughter: new issues for lawyers.

The Times, 3 Sep. p.4b.

(In the page reference. p.4b - "4" indicates that the article is on the fourth page of the newspaper, columns of print on a page are labelled left to right alphabetically, so in this example "b" indicates that this is the second column of newsprint across the page from left to right.)

An example of corporate authorship where the newspaper article authorship is not stated.

Times, 2005. Corporate manslaughter: responses from the legal profession (Editorial comments), The Times, 8 Sep. p.4b.

Online newspaper articles

For newspaper articles found in online newspapers, the required elements for a reference are:

Author or corporate author, Year.Title of document or page.Name of newspaper, [type of medium] additional date information. Available at: [Accessed date].

Chittenden, M., Rogers, L. and Smith, D., 2003. Focus: 'Targetitis ails NHS. Times Online, [online]1 June. Available at:http://www.timesonline.co.uk/tol/news/uk/scotland/article1138006.ece

[Accessed 17 March 2005].

Coney, J., 2009. Is this the start of a new home loan war HSBC vows to lend £1billion to homebuyers with 10% deposits. Daily Mail, [online] (Last updated 9.47 AM on 09th April 2009). Available at:http://www.dailymail.co.uk/news/article-1168461/Is-start-new-home-loan-war-HSBC-vows-lend-1billion-homebuyers-10-deposits.php

[Accessed on 20 April 2009].

An intext reference for the above examples would read:

(Chittenden, et al. 2003)

(Coney, 2009)

Using Other Source Types

Acts of Parliament

The required elements are:

Short title (with key words capitalized), which includes the year followed by the chapter number in brackets. Place of publication: Publisher.

Higher Education Act 2004. (c.8). London: HMSO.

For Acts prior to 1963, the regal year and parliamentary session are included:

Road Transport Lighting Act 1957. (5&6 Eliz. 2, c.51). London: HMSO.

If you need to refer to a specific section and paragraph, include the section, paragraph number and subsection. Finance Act 2007. s.45(9)(b).

Satutory instruments

The required elements for a reference are:

Short title (with key words capitalized). Year. the abbreviation 'SI' followed by the year of publication and the SI number. Place of publication: Publisher.

Public Offers of Securities Regulations 1995. 1995 SI 1995/1537. London: HMSO.

Official publications such as Command Papers

The required elements for a reference are:

Authorship, which may be part of the title, Year. Title, in italics if a separate element, Offically assigned number such as a Command number as it is on the document, within brackets. Place of publication: Publisher.

Royal Commission on civil liability and compensation for personal injury, 1978. (Pearson Report) (Cmnd. 7054). London: HMSO.

Select Committee on nationalised industries (1978-9), 1978. Consumers and the nationalised industries: prelegislative hearings (HC 334, 1978-9). London: HMSO.

House of Commons, Home Affairs Committee, 2012. The Work of the Border Force. (HC 523, Sixth Report of Session 2012-13) - Report, Together with Formal Minutes. London:TSO (The Stationery Office).

Law reports

It is recommended that you follow accepted legal citation, which is not part of the Harvard system. For this the required elements for a reference are:

Name of the parties involved in the law case, Year of reporting (in square brackets where there is no volume, or round brackets as indicated by the reference you are using) abbreviation for the law reporting series, part number/case number/page reference if available.

Jones v Lipman [1962] 1 WLR 832.

Saidi v France (1994) 17 EHRR 251, p.245.

R v White (John Henry) [2005] EWCA Crim 689, 2005 WL 104528.

In the last example you should only quote the two law reports if you have used them.

An intext reference for the above example would read:

In the recent case of R v White (John Henry) (2005), the defence noted ...

Annual report

The required elements for a reference are:

Corporate author, Year. Full title of annual report, Place of Publication: Publisher.

Marks & Spencer, 2004. The way forward, Annual report 2003-2004, London: Marks & Spencer.

For an e-version of an annual report. The required elements for a reference are:

Author or corporate author, Year. Title of document or page, [type of medium]

Available at: include web site address/URL(Uniform Resource Locator)

[Accessed date]

Marks & Spencer, 2004. Annual report 2003-2004. [online]

Available at:

[Accessed 4 June 2005].

Archive material

If you have used material from archives or special collections, the required elements for a reference are:

Author, Initials., Year. Title of document. [type of medium] Collection, Document number. Geographical Town/Place: Name of Library/Archive/Repository.

Brown, P.S., 1915. An address to the Farmer. [manuscript] Holdbury Collection. 600. London: Holdbury Library.

An intext reference for the above example would read:

(Brown, 1915)

British Standards and International Standards

The required elements for a reference are:

Corporate author, Year of Publication. Identifying letters and numbers and full title of Standard, Place of publication: Publisher.

British Standards Institution, 1990. BS 5555:1990 Recommendations for wiring identification. Milton Keynes: BSI.

International Standards Office, 1998. ISO 690 - 2 Information and documentation: Bibliographical references: Electronic documents. Geneva: ISO.

The required elements for an e-version are:

Corporate author, Year. Identifying letters and numbers and full title of Standard. Place of publication (if available): Publisher [online] Available through: Anglia Ruskin University Library website <http://libweb.anglia.ac.uk> [Accessed date].

British Standards Institution, 2011. BS EN 594:2011 Timber structures. Test methods. Racking strength and stiffness of timber frame wall panels. British Standards Online [online] Available through: Anglia Ruskin University Library website <http://libweb.anglia.ac.uk> [Accessed 31 August 2011].

Patents

The required elements for a reference are:

Inventor name, Initials., Assignee., Year. Title. Place. Patent number (status, if an application).

Example:

Graham, C.P., Fonti, L. and Martinez, A.M., American Sugar Co. 1972. Tableting sugar and compositions containing it. U.S. Pat. 3,642,535.

Leonard, Y., Super Sports Limited. 2008. Tin can manufacture and method of sealing. Canada. Pat. 12,789,675.

Conference reports and papers

The required elements for a conference report are:

Authorship, Year. Full title of conference report. Location, Date. Place of publication: Publisher.

UNDESA (United Nations Department of Economic and Social Affairs), 2005. 6th Global forum on reinventing government: towards participatory and transparent governance. Seoul, Republic of Korea, 24-27 May 2005. New York: United Nations.

The required elements for a conference paper are:

Author, Initials., Year. Full title of conference paper. In: followed by editor or name of organisation, Full title of conference. Location, Date. Place of publication: Publisher.

Brown, J., 2005. Evaluating surveys of transparent governance. In: UNDESA (United Nations Department of Economic and Social Affairs), 6th Global forum on reinventing government: towards participatory and transparent governance. Seoul, Republic of Korea, 24-27 May 2005. New York: United Nations.

Reports by organisations

The required elements for a reference are:

Authorship/Organisation, Year. Full title of report. Place: Publisher:

Department of Health, 2001. National service framework for older people. London: Department of Health.

Coulter, A. and Collins, A., 2011. Making shared decision-making a reality: no decision about me, without me. London: The King's Fund.

The required elements for an e-version are:

Authorship/Organisation, Year. Full title of report. [type of medium] Place: Publisher. Available at: include web address/URL [Accessed on date].

Department of Health, 2001. National service framework for older people. [pdf] London: Department of Health. Available at:http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4071283.pdf[Accessed 12 September 2011].

Coulter, A. and Collins, A., 2011. Making shared decision-making a reality: no decision about me, without me. [pdf] London: The King's Fund. Available at:http://www.kingsfund.org.uk/publications/nhs_decisionmaking.php[Accessed 12 September 2011].

Dissertations and Theses

The required elements for a reference are:

Author, Initials., Year of publication. Title of dissertation. Level. Official name of University.

Richmond, J., 2005. Customer expectations in the world of electronic banking: a case study of the Bank of Britain. Ph. D. Anglia Ruskin University.

The required elements for an e-version are:

Author, Initials., Year of publication. Title of dissertation. Level. Official name of University. Available at [Accessed on date].

Fisher, C. W., 2008. The legacy of leadership - a study of leadership influence within a single organisation. DEd. University of Sheffield. Available at: [Accessed 30.07.2012].

European union documents

Following EU conventions, examples of various EU documents are given below:

The required elements for a reference are:

The name of the Institution where the document originates (e.g. Commission) Form (eg Directive or Decision) Year/Legislation number/ Initials of Institution followed by the date it was passed if known, followed by the title, all in italics.

Council Directive 2001/29 /EC of 22 May 2001 on the harmonisation of certain aspects of copyright and related rights in the information society.

Commission Decision 93/42/EEC of 21 December 1992 concerning additional guarantees relating to infectious bovine rhinotracheitis for bovines destined for Denmark.

EU Regulation 1408/71

REGULATION (EEC) No 1408/71 OF THE COUNCIL of 14 June 1971 on the application of social security schemes to employed persons and their families moving within the Community.

Council Regulation (EEC) 1612/68[5] of 15 October 1968 on freedom of movement for workers within the Community.

Course material and lecture notes

It is important to check with the lecturer who has given the lecture that they are in agreement with course material being included in any Reference List. If they are in agreement, and if it is not a publicly available document, it is important to provide a copy in the Appendix of your work. The citation to the course material in your Reference List should then also refer to the Appendix.

It would also be advisable to follow up any sources mentioned in your lecture and read these for yourself.

Course material / lecture notes - print version

The required elements for a reference are:

Lecturer/Author, Initials., Year. Title of item, Module Code Module title. HE Institution, unpublished.

Williams, B., 2008. Guide to project management, BD45001S Management. Anglia Ruskin University, unpublished.

An intext reference for the above example would read:

(Williams, 2008)

Course material - electronic

The required elements for a reference are:

Lecturer/Author, Initials., Year. Title of item, Module Code Module Title [online via internal VLE], HE Institution. Available at: web address if available over the internet, otherwise indicate if available through WebCT, SharePoint or other virtual learning environment address. [Accessed date].

Williams, B., 2008. Guide to project management, BD45001S Management. [online via internal VLE] Anglia Ruskin University Available at: [Accessed Date 13 June 2008].

An intext reference for the above examples would read:

(Williams, 2008) ...

Quotations from written plays

When reviewing a number of different plays it is essential to cite the title of the plays. If reviewing one play (for example Twelfth Night) it is not necessary to repeat the title in your citations.

Published plays may contain line numbers, particularly in classic texts such as Shakespeare. If they exist it is good practice to include the line number, but Act and Scene numbers must always be included.

Classic plays are available in edited editions and the editor's name should be included with your reference.

The required elements for a reference are:

Author, Initials., Year (of the edition). Title of play. Editors, Edition. (only include this if not the first edition) Place of publication: (this must be a town or city, not a country) Publisher.

Shakespeare, W. 1995. Twelfth Night. (World's Classics series) Warren, R. and Wells, T. eds. Oxford: Oxford University Press.

An intext reference for the above examples would read:

Much speculation has occurred when Malvolio imagines he might marry Olivia, "there is example for't; the Lady of the Strachy married the yeoman of the wardrobe" (Shakespeare, Twelfth Night II,v,36-7).

Interviews

Where you have conducted an interview - using a primary source. You are recommended to check with your Faculty Office for detailed guidance on what you may include.

Where you are conducting the interview, it is important to check with the person being interviewed that they will be in agreement with a transcript of the interview being made available. Since this will not be a publicly available document, it may be included as a transcript within an Appendix in your piece of work.

The citation for this interview should refer to the Appendix.

In an interview (Appendix A) the findings of the report were reviewed and White agreed with ...

In the Appendix you should include details such as:

Interviewee's name. Year of interview. Title of interview. Interviewed by ...name. [type of medium/format] Location and exact date of interview . Together with the transcript.

Where you are using an interview from a source such as a television programme

The suggested elements for a reference are:

Interviewee name, Initials., Year of Interview. Title of Interview. (or Interview on ..name of programme) Interviewed by ...name (first name and surname). [type of medium/format] Name of Channel, Date of transmission, time of transmission.

Ahern, B., 1999. Interview on Morning Ireland. Interviewed by... John Boyd [radio] RTE Radio 1, 15 February 1999, 08:30.

An intext reference for the above examples would read:

(Ahern, 1999)

Press release

These may be print or electronic.

For a print press release:

Corporate author of press release, Year. Title. Press release, date.

RCN, 2009. RCN praises health care staff as infections continue to fall. Press release, 18 June 2009.

For an electronic press release:

Corporate author of press release, Year. Title. [press release] date. Available at: web address [Accessed date].

RCN, 2009. RCN praises health care staff as infections continue to fall. [press release] 18 June 2009. Available at:http://www.rcn.org.uk/newsevents/news/article/uk/rcn_praises_health_care_staff_as_infections_continue_to_fall[Accessed 23 June 2009].

Department of Health, 2011. Act F.A.S.T. campaign relaunched to save more lives. [press release] 28 February 2011. Available at:http://www.dh.gov.uk/en/MediaCentre/Pressreleases/DH_124696[Accessed 15 April 2012].

Religious texts

When you are quoting from a sacred text e.g. the Bible, the Torah or the Quran, the suggested elements for a citation are:

Name of religious text, Book. Sura or Chapter: Verse

An in-text reference for the Bible could look like this...

"In the beginning, God created the heavens and the earth" (The Bible, Genesis. 1:1)

Convention dictates that you do not use page numbers with religious texts

The required elements for a full reference are:

Full title, Year. Place of publication: Publisher.

The Bible: contemporary English version, 2000. London: Harper Collins.

For other sacred texts, it is important that you clearly identify the location of the text that you cite using the appropriate numbering system.

Reference from dictionary

When you are quoting a definition from a dictionary, use the publisher as the author.

The required elements for a citation are:

(Publisher, Year)

(Chambers, 2010)

For the reference

The suggested elements for a reference are:

Dictionary publisher, Year. Full title of dictionary. Place of Publication: Publisher.

Chambers, 2010. Chambers paperback dictionary thesaurus. London: Champers Harpers Publishers Ltd.

Encyclopaedia Britannica, 2012. Encyclopaedia Britannica Online. [online] London: Encyclopedia Britannica (UK). Avaialble through:encyclopaediabritannica.co.uk/intro[Accessed 12 June 2011].

Data Sources

Where data it extracted from a data source such as Isurv or FAME, both the source with the year of currency for that data. should be acknowledge in an intext reference.

Complete details should be included in the reference list.

RICS ISurv, 2013. More new homes. [Building surveying > Pathology > Modern methods of construction > Meeting challenges with MMC] ISurv [online] Available through: Anglia Ruskin University Library [Accessed 21 May 2013].

Where you have gathered and manipulated data from a data source like FAME or OECD and placed this in a table of your own making, we recommend that you give the source and year of currency, for the data, as an the intext reference and include a note to an appendix. In the appendix you can reproduce the source tables you have used to create your table and include adequate details of how you generated the table you have used in your work.

Computer Program

For a computer program downloaded from the internet, the required elements of a references are:

Authorship/Organisation, Year. Title of program. (Version). [computer program] Distributor/Publisher. (if available) Available at: [Accessed date]

Adobe Systems Incorporated, 2013. Adobe Air (3.8 beta). [computer program] Adobe Labs. Available at:http://labs.adobe.com/technologies/flashruntimes/air/[Accessed 30 August 2013].

Using Electronic Sources

Websites

For websites found on the worldwide web the required elements for a reference are:

Authorship or Source, Year.Title of web document or web page. [type of medium] (date of update if available) Available at: include web site address/URL (Uniform Resource Locator) [Accessed date].

If the URL appears to be exceedingly long, provide routing details which enable the reader to access the particular page via the site's homepage. You may be taken to a particular page as a result of a search you performed, or be directed from a link to another place on a website. The resultant URLs may include specific data about your method of accessing that page that is not available to your reader. If this is the case use the homepage (from which the reference can be found).

NHS Evidence, 2003.National Library of Guidelines. [online] Available at: [Accessed 10 October 2009].

Publications available from websites

For publications found on the internet the required elements for a reference are:

Author or corporate author, Year.Title of document. [type of medium] Place: Producer/Publisher. Available at: include web site address/URL(Uniform Resource Locator) [Accessed date].

Boots Group Plc., 2003. Corporate social responsibility. [online] Boots Group Plc. Available at: [Accessed 23 July 2005].

Defoe, D., 1999. The fortunes and the misfortunes of the famous Moll Flanders. [online] Champaign, Illinois: Project Gutenberg. Available at: [Accessed 18 November 2005].

Independent Inquiry into Access to Healthcare for People with Learning Disabilities, n.d. Healthcare for all. [online] Available at: [Accessed 10 April 2009].

Scottish Intercollegiate Guidelines, 2001.Hypertension in the elderly. (SIGN publication 20) [online] Edinburgh: SIGN (Published 2001) Available at: [Accessed 17 March 2005].

E-mail correspondence/discussion lists

Particular care needs to be taken if you are quoting from these as they may include personal email addresses and be from a restricted source.

Permission should be sought before these sources are quoted.

For email correspondence or discussion lists the suggested elements for a reference are:

Name of sender, email address, Year.Message or subject title from posting line. [type of medium] Recipient's name and (email address). Date sent: Including time. Available at: URL (e.g. details of where message is archived) [Accessed date].

Jones, P., jones@jones.com, 2005.Mobile phone developments. [email] Message to R G. Schmit (r.g.schmit@syy.ac.uk).Sent Monday 7 June 2005: 08:13. Available at: [Accessed 7 July 2005].

Copies of such correspondence should be kept, as these may need to be submitted as an appendix in an academic submission

Blogs

The required elements for a reference are:

Author, Initials., Year. Title of individual blog entry.Blog title, [medium] Blog posting date. Available at: include web site address/URL (Uniform Resource Locator) [Accessed date].

Whitton, F., 2009. Conservationists are not making themselves heard. Guardian.co.uk Science blog, [blog] 18 June. Available at: [Accessed 23 June 2009].

Blog comments

The required elements for a reference are:

Comment Author, Year. Title of individual blog entry.Blog title, [medium] Comment posting date. Available at: include web site address/URL (Uniform Resource Locator) [Accessed date].

DGeezer, 2009. Conservationists are not making themselves heard. Guardian.co.uk Science blog, [blog] 18 June, Available at: [Accessed 23 June 2009].

An in text reference for the above examples would read:

(Whitton, 2009)

(DGeezer, 2009)

Mailing list

The required elements for a reference are:

Author, Initial., Year. Subject line, Title of Mailing List. [online] date of message. Available at: include web site address/URL (Uniform Resource Locator) [Accessed date].

Murrey, T., 2009.Sharing good practice, Forum for International Students. [online] 23 June 2009. Available at: [Accessed 23 June 2009].

Social Media

The required elements for a reference are:

Author, Initials., Year. Title of page [Facebook].Day/month post written. Available from: [ Accessed date].

Andrews, A., 2012. Customer Focus Group [Facebook]. 11 November . Available at: [Accessed 11 November 2010].

Author, Initials., Year. Full text of tweet [Twitter].Day/month tweet written. Available at: [Date accessed].

Big Red Corporation. 2013. New products for cars [Twitter]. 17 May Available at: [Accessed 13 November 2010].

Unpublished Works

Unpublished works

You may occasionally have access to a document before it is published and may therefore not be able to provide full details:

Pattison, J., (in press) A new book that I have written. London: Vanity Press.

Woolley, E. and Muncey, T., (in press) Demons or diamonds: a study to ascertain the range of attitudes present in health professionals to children with conduct disorder. Journal of Adolescent Psychiatric Nursing.(Accepted for publication December 2002).

Informal or in-house publications

For informal publications, such as class handouts and leaflets, provide what details you can:

Anglia Ruskin University, 2007.Using the Cochrane Library. [leaflet] August 2007 ed. Cambridge: Anglia Ruskin University.

Personal communication

Where you refer to a more informal personal communication, e.g. letter, email, phone call or conversation, provide as much detail as possible and note the nature of the communication.

Permission should be sought before these sources are quoted, and a copy retained for reference.

Hindle, E., 2000. Introducing Cow & Gate Omneo Comfort: an infant milk for digestive comfort. [letter] (Personal communication, 2 June 2000).

O'Sullivan, S., 2003.Discussion on citation and referencing. [letter] (Personal communication, 5 June 2003).

Images

DVD, video or film

The required elements for a reference are:

Full title of DVD or video. Year of release. [type of medium] Director. (if relevant) Country of origin: Film studio or maker. (Other relevant details).

Great films from the 80s: a selection of clips from Warner Brothers top films from the 1980s. 2005 [DVD] New York: Warner Brothers.

Health for all children 3: the video. 2004. [video] London: Child Growth Foundation. (Narrated by D.B.M. Hall).

For a film the suggested elements should include:

Title. Year of release. [Medium] Director. Country of origin: Film studio.

Macbeth, 1948. [Film] Directed by Orson Welles. USA: Republic Pictures

Broadcasts

For a broadcast the suggested elements should include:

Series title and episode name and number if relevant, Year of broadcast. [type of medium] Broadcasting organisation and Channel, date and time of transmission.

Little Britain, 2006. [TV programme] BBC, BBC2, 30 January 2006 20.00.

For a broadcast obtained through Box of Broadcasts

Little Britain, 2006. [TV programme recording] BBC, BBC2, 30 January 2006 20:00. Available through: Box of Broadcasts database [Accessed 12 August 2011].

Pictures, Images and photographs

The suggested elements for a reference are:

Artist/Photographer's name (if known), Year of production. Title of image. [type of medium] Collection Details as available (Collection, Document number, Geographical Town/Place: Name of Library/Archive/Repository).

Beaton, C., 1956. Marilyn Monroe. [photograph] (Marilyn Monroe�s own private collection).

Beaton, C., 1944. China 1944: A mother resting her head on her sick child's pillow in the Canadian Mission Hospital in Chengtu. [photograph] (London, Imperial War Museum Collection).

For an electronic reference the suggested elements are:

Artist/Photographer's name, Year of production. Title of image. [type of medium] Available at: include web site address/URL(Uniform Resource Locator) and additional details of access, such as the routing from the homepage of the source. [Accessed date].

Dean, R., 2008. Tales from Topographic Oceans. [electronic print] Available at: [Accessed 18 June 2008].

Image taken from Bridgemean Education database

Peeters, C., ca. 164?. Still life of fish and lemons. (Bridgeman Education database) [image online] Available through: Anglia Ruskin University Library website [Accessed 12 June 2013]

Electronic images

For images found on the internet the required elements for a reference are:

Author, Year (image created). Title of work. [type of medium] Available at: include web site address/URL (Uniform Resource Locator) [Accessed date].

Where the author is not known, begin the reference with the title of the work.

Where none of the usual details are known, (such as author, date, or image title) try to find the filename of the image (for example by right clicking and looking at the properties of the file). If none of the above is available begin the reference with the subject and title of the work.

[Child placing gauze over knee wound] n.d. [image online] Available at: < http://www.dadpal.com/2009/12/wounds-care-help-and-wound-vac-therapy.php> [Accessed 01 June 2010].

[Nimbus 1 returned sharp cloud cover photos, plus night time infra red pictures] n.d. [image online] Available at: [Accessed 13 November 2008].

Pepsi, 2009. Pepsi can designs. [image online] Available at: [Accessed 19 June 2009].

Van Vechten, C. 1934. Man Ray. [photograph] Available at: [Accessed 04 October 2009].

An in text reference for the above examples would read:

(Child placing gauze, n.d.)

(Nimbus 1, n.d.)

(Pepsi, 2009)

(Van Vechten, 1934)

Maps-Print Maps, Digimap and Google Earth

The required elements for a reference are:

Map maker, Year of issue. Title of map. Map series, Sheet number, scale. Place of publication: Publisher.

Ordnance Survey, 2006. Chester and North Wales. Landranger series, Sheet 106, 1:50000. Southampton: Ordnance Survey. The required elements for Digimap are:

Map publisher (origin), Year of publication. Created map title, Scale. Source [online] Available through Library website [Accessed date].

Ordinance Survey, 2011. Anglia Ruskin University: Chelmsford Campus, 1:1.500. EDINA Digimap [online] Available through: Anglia Ruskin University Library [Accessed 31 August 2011].

The suggested elements for Google Earth are:

Google Earth version (if applicable), Year data released. Image details - location, co-ordinates, elevation. Data set (if applicable) [online] Available through: URL [Accessed date].

Google Earth 6.0, 2008. Hylands House and Estates 51°42'39.17"N, 0°26'11.30"W, elevation 60M. 3D Buildings data layer. Available through: [Accessed 31 August 2011].

Podcast and archived TV programme

The required elements for a reference are:

Broadcaster/Author, Year. Programme title, Series Title. (if relevant) [type of medium] date of transmission. Available at: include web site address/URL (Uniform Resource Locator) [Accessed date].

National Gallery, 2008. Episode Seventeen (March 2008), The National Gallery Monthly Podcast. [podcast] March 2008. Available at: < http://www.nationalgallery.org.uk/podcasts> [Accessed 23 June 2009].

YouTube video

The required elements for a reference are:

Screen name of contributor, Year. Video Title, Series Title. (if relevant) [type of medium] Available at: include web site address/URL (Uniform Resource Locator) [Accessed date].

Mrgeorged, 2009. Top Gear The Stig revealed Full. [video online] Available at: [Accessed 23 June 2009].

Defra, 2007. Sustainable development: the bigger picture. [video online] Available at: [Accessed 23 June 2012].

An in text reference for the above example would read:

The principle research states "The need for substainable development..." (Defra 2007)

Most Viewed

Challenges of oral antithrombotic therapy in breast cancer patients treated with cyclin-dependent kinase inhibitors: A case report

Jorge Illarramendi MD Nuria Aymerich MD María Herrera MD Julia Coll MD Jose Juan Illarramendi MD

Case Report-Hematology and Medical Oncology (HMO)

July 12, 2021


STAMP inhibitor Asciminib and medium-chain fatty-acid derivative AIC-47: novel therapies for chronic myeloid leukemia

Satoshi Uchiyama Haruka Shinohara SungGi Chi Rikako Tabata Yong-Mei Guo Junichiro Yuda Takaaki Ono Yosuke Minami

Review Article-Hematology and Medical Oncology (HMO)

July 15, 2021


Abdominal inflammatory myofibroblastic tumour in a 4 month old baby- A case report

Abhishek Kumar Jha Lipika Lipi Meera Luthra Kulbir Ahlawat

Case Report-Hematology and Medical Oncology (HMO)

July 23, 2021


The clinical case of an oncological patient affected by mandibular osteonecrosis and literature review about therapeutic alternatives

Francesca Marasciulo Giuseppe Lomurno Mario Mandalà Fausto Roila

Case Report-Hematology and Medical Oncology (HMO)

June 25, 2021


Laproscopic and robotic management of obstructive ureteral injuries: A Review

Khalid Deshmukh Gaaminepreet Singh

Review Article-Hematology and Medical Oncology (HMO)

June 30, 2021


Submit your Next Article

  • Online submission
  • Highly indexed and abstracted
  • 7 years of successful publishing
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review